Skip to content
Find a Provider
John M. Bennett, M.D.

John M. Bennett, M.D.

UR Medicine Labs

No ratings currently available, see text in Ratings section below for explanation.

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Not Accepting New Patients

Contact

Fax (585) 276-2390
Administrative (585) 275-1959

About Me

Dr. Bennett is Professor Emeritus of Medicine, Pathology and Laboratory Medicine at the University of Rochester Medical Center, in Rochester, New York. He received his undergraduate degree from Harvard University and his medical degree from Boston University. Postgraduate training included an intern...
Dr. Bennett is Professor Emeritus of Medicine, Pathology and Laboratory Medicine at the University of Rochester Medical Center, in Rochester, New York. He received his undergraduate degree from Harvard University and his medical degree from Boston University. Postgraduate training included an internship at Massachusetts Memorial Hospital, a residency in medicine at Beth Israel Hospital, a fellowship in hematology at Boston City Hospital and Tufts University.

From 1963-1966 he was head of the hematology laboratories at the Beth Israel Hospital in Boston. He served in the USPHS as Head of the diagnostic bone marrow laboratories in the NIH/Clinical Center from 1966-1968. Director of the Cancer center in 1974. A position he held until 1995. During this period he was the principal investigator of the University of Rochester ECOG membership.

He served as chair of the ASCO Public Relations Committee in the early 1980's as well as chair of the Education Committee for ASH. He was a founding member of the International Society for Geriatric Oncology.

He is a member of numerous professional societies, including the American Medical Association, American Association for the Advancement of Science, American Association for Cancer research, American Society for Clinical Oncology, American Society of Hematology and the International Society of Hematology, and was the first chair of The Myelodysplastic Syndromes Foundation from 1997-2010. Dr. Bennett has contributed over 560 publications to the medical literature as well as several books and was the Editor-in-Chief of the Leukemia Research Journal for 20 years from 1993 - 2013.

Certified Specialties

Internal Medicine - American Board of Internal Medicine

Medical Oncology - American Board of Internal Medicine

Faculty Appointments

Professor Emeritus - Department of Medicine, Hematology/Oncology (SMD)

Credentials

Residency & Fellowship

Fellowship, Hematology, Boston University Medical Center (USA). 1962 - 1963

Residency, Internal Medicine, Beth Israel Deaconess Medical Center-Main Campus. 1960 - 1962

Internship, Internal Medicine, University of Massachusetts Memorial Hospital. 1959 - 1960

Education

MD | Boston University School of Medicine. 1959

Awards

Lifetime Achievement Award in Myelodyplastic Syndromes. 2024

ASCP use of Journal Article for CQI Modules: Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis. 2020

BJ Kennedy Award & Lecture for Scientific Excellence in Geriatric Oncology. 2011

Research Career Achievement in Clinical Hematology Award by Celgene. 2003

Honorary Professor. 2001

Guest Consulting Editor for Geriatric Oncology: CA: A Cancer Journal for Clinicians. 2001

National Counselor for the U.S.A.: International Society of Hematology. 1998

Chairman, The Myelodysplastic Syndromes Foundation. 1996

Editor-in-Chief: Leukemia Research. 1993

The Best Doctors in America: Inclusion in the directory. 1992

Chairman, Committee on Cancer. 1990

Chairman, Symposium on "Myelodysplastic Syndromes: Pathology and Management. 1988

Associate Director, Tutorial on Neoplastic Hematopathology. 1988

Distinguished Alumnus Award. 1986

Marquis Who's Who Directory of Professionals and Resources in Cancer. 1984

Chairman, Education Program Committee. 1982 - 1983

Chairman, Council for Research & Investigation Awards. 1982 - 1983

Chairman, Public Relations Committee. 1982 - 1985

Member, International Committee for Standardization in Hematology. 1982

Chairman, Cancer Clinical Investigation Review Committee. 1979 - 1980

C.H.A.M.P. Award: Jacob Gitelman Award for Cancer Action. 1977

Faculty Senate. 1975

Secretary of Steering Committee. 1975

Chairman, American Cancer Society Review Committee. 1975

Executive Committee, Eastern Cooperative Oncology Group. 1975

Hematology Committee Chairman. 1974

Vice-Chairman, American Cancer Society Review Committee. 1974

Founder: French-American-British Cooperative Leukemia Working Group.

Publications

Journal Articles

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.

Komrokji RS, Lanino L, Ball S, Bewersdorf JP, Marchetti M, Maggioni G, Travaglino E, Al Ali NH, Fenaux P, Platzbecker U, Santini V, Diez-Campelo M, Singh A, Jain AG, Aguirre LE, Tinsley-Vance SM, Schwabkey ZI, Chan O, Xie Z, Brunner AM, Kuykendall AT, Bennett JM, Buckstein R, Bejar R, Carraway HE, DeZern AE, Griffiths EA, Halene S, Hasserjian RP, Lancet J, List AF, Loghavi S, Odenike O, Padron E, Patnaik MM, Roboz GJ, Stahl M, Sekeres MA, Steensma DP, Savona MR, Taylor J, Xu ML, Sweet K, Sallman DA, Nimer SD, Hourigan CS, Wei AH, Sauta E, D'Amico S, Asti G, Castellani G, Delleani M, Campagna A, Borate UM, Sanz G, Efficace F, Gore SD, Kim TK, Daver N, Garcia-Manero G, Rozman M, Orfao A, Wang SA, Foucar MK, Germing U, Haferlach T, Scheinberg P, Miyazaki Y, Iastrebner M, Kulasekararaj A, Cluzeau T, Kordasti S, van de Loosdrecht AA, Ades L, Zeidan AM, Della Porta MG,

The Lancet. Haematology.. 2024 October 8 Epub 10/08/2024.

Contemporary Approach to The Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes- Recommendations from The International Consortium for MDS (icMDS).

Aakash F, Gisriel SD, Zeidan AM, Bennett JM, Bejar R, Bewersdorf JP, Borate UM, Boultwood J, Brunner AM, Buckstein R, Carraway H, Churpek JE, Daver NG, DeZern AE, Efficace F, Fenaux P, Figueroa ME, Garcia-Manero G, Gore SD, Greenberg PL, Griffiths EA, Halene S, Hourigan CS, Kim TK, Kim N, Komrokji RS, Kutchroo V, List AF, Little RF, Majeti R, Nazha A, Nimer SD, Odenike O, Padron E, Patnaik MM, Platzbecker U, Della Porta MG, Roboz GJ, Sallman DA, Santini V, Sanz G, Savona MR, Sekeres MA, Stahl M, Starczynowski DT, Steensma DP, Taylor J, Abdel-Wahab O, Wei AH, Zhuoer X, Xu ML, Hasserjian RP, Loghavi S

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2024 September 23 :100615. Epub 09/23/2024.

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).

Stahl M, Bewersdorf JP, Xie Z, Porta MGD, Komrokji R, Xu ML, Abdel-Wahab O, Taylor J, Steensma DP, Starczynowski DT, Sekeres MA, Sanz G, Sallman DA, Roboz GJ, Platzbecker U, Patnaik MM, Padron E, Odenike O, Nimer SD, Nazha A, Majeti R, Loghavi S, Little RF, List AF, Kim TK, Hourigan CS, Hasserjian RP, Halene S, Griffiths EA, Gore SD, Greenberg P, Figueroa ME, Fenaux P, Efficace F, DeZern AE, Daver NG, Churpek JE, Carraway HE, Buckstein R, Brunner AM, Boultwood J, Borate U, Bejar R, Bennett JM, Wei AH, Santini V, Savona MR, Zeidan AM

Blood reviews.. 2023 November 62 :101128. Epub 08/19/2023.

Acute myelofibrosis superseding B-lymphoblastic leukemia/lymphoma.

El Hussein S, O'Dywer KM, Bennett JM

EJHaem.. 2023 November 4 (4):1179-1181. Epub 08/08/2023.

Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis.

Foran JM, Sun Z, Lai C, Fernandez HF, Cripe LD, Ketterling RP, Racevskis J, Luger SM, Paietta E, Lazarus HM, Zhang Y, Bennett JM, Levine RL, Rowe JM, Litzow MR, Tallman MS

Cancer.. 2023 August 15129 (16):2479-2490. Epub 04/25/2023.

ICC-2022 versus WHO-2022 classification systems for acute leukemias and myeloid neoplasms: The perspective from two classical morphologists.

Zini G, Bennett JM

American journal of hematology.. 2023 August 98 (8):E209-E211. Epub 05/22/2023.

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.

Stahl M, Abdel-Wahab O, Wei AH, Savona MR, Xu ML, Xie Z, Taylor J, Starczynowski DT, Sanz GF, Sallman DA, Santini V, Roboz GJ, Patnaik MM, Padron E, Odenike O, Nazha A, Nimer SD, Majeti R, Little RF, Gore SD, List AF, Kuchroo V, Komrokji RS, Kim TK, Kim N, Hourigan CS, Hasserjian RP, Halene S, Griffiths EA, Greenberg PL, Figueroa ME, Fenaux P, Efficace F, DeZern AE, Della Porta MG, Daver NG, Churpek JE, Carraway HE, Brunner AM, Borate U, Bennett JM, Bejar R, Boultwood J, Loghavi S, Bewersdorf JP, Platzbecker U, Steensma DP, Sekeres MA, Buckstein RJ, Zeidan AM

Blood advances.. 2023 June 277 (12):2709-2714. Epub 1900 01 01.

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.

Zeidan AM, Bewersdorf JP, Buckstein R, Sekeres MA, Steensma DP, Platzbecker U, Loghavi S, Boultwood J, Bejar R, Bennett JM, Borate U, Brunner AM, Carraway H, Churpek JE, Daver NG, Della Porta M, DeZern AE, Efficace F, Fenaux P, Figueroa ME, Greenberg P, Griffiths EA, Halene S, Hasserjian RP, Hourigan CS, Kim N, Kim TK, Komrokji RS, Kutchroo V, List AF, Little RF, Majeti R, Nazha A, Nimer SD, Odenike O, Padron E, Patnaik MM, Roboz GJ, Sallman DA, Sanz G, Stahl M, Starczynowski DT, Taylor J, Xie Z, Xu M, Savona MR, Wei AH, Abdel-Wahab O, Santini V

Leukemia.. 2022 December 36 (12):2939-2946. Epub 10/20/2022.

Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms.

Patnaik MM, Zeidan AM, Padron E, Platzbecker U, Sallman DA, DeZern AE, Bejar R, Sekeres M, Taylor J, Little RF, Bewersdorf JP, Kim TK, Kim N, Hourigan CS, Dela Porta MG, Stahl M, Steensma D, Xu ML, Odenike O, Carraway H, Fenaux P, Nazha A, Komrokji R, Loghavi S, Xie Z, Hasserjian R, Savona M, Bennett JM

Leukemia.. 2022 December 36 (12):2934-2938. Epub 11/05/2022.

Mast cell leukemia morphologic illustration of a rare entity.

Syposs CR, Evans AG, Bennett JM, Liesveld JL, El Hussein S

EJHaem.. 2022 November 3 (4):1422-1424. Epub 09/09/2022.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.

El Hussein S, Yabe M, Wang W, Pemmaraju N, Loghavi S, Jelloul FZ, Fang H, Medeiros LJ, Burack WR, Evans AG, Liesveld JL, Bennett JM

EJHaem.. 2022 August 3 (3):954-957. Epub 07/03/2022.

Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update.

Jain AG, Zhang L, Bennett JM, Komrokji R

Annals of laboratory medicine.. 2022 May 142 (3):299-305. Epub 1900 01 01.

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.

Greenberg PL, Stone RM, Al-Kali A, Bennett JM, Borate U, Brunner AM, Chai-Ho W, Curtin P, de Castro CM, Deeg HJ, DeZern AE, Dinner S, Foucar C, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Jonas BA, Keel S, Madanat Y, Maness LJ, Mangan J, McCurdy S, McMahon C, Patel B, Reddy VV, Sallman DA, Shallis R, Shami PJ, Thota S, Varshavsky-Yanovsky AN, Westervelt P, Hollinger E, Shead DA, Hochstetler C

Journal of the National Comprehensive Cancer Network : JNCCN.. 2022 February 20 (2):106-117. Epub 1900 01 01.

The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-T.

Kaivers J, Peters J, Rautenberg C, Schroeder T, Kobbe G, Hildebrandt B, Haas R, Germing U, Bennett JM

Leukemia research.. 2022 January 112 :106757. Epub 11/26/2021.

Mast cell leukemia morphologic illustration of a rare entity

Chauncey R. Syposs,Andrew G. Evans,John M. Bennett,Jane L. Liesveld,Siba El Hussein.

eJHAEM British Journal for Haemotology. 2022; 3(4): 1422-24.

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial.

DiNardo CD, Schuh AC, Stein EM, Montesinos P, Wei AH, de Botton S, Zeidan AM, Fathi AT, Kantarjian HM, Bennett JM, Frattini MG, Martin-Regueira P, Lersch F, Gong J, Hasan M, Vyas P, Döhner H

The Lancet. Oncology.. 2021 November 22 (11):1597-1608. Epub 10/18/2021.

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin.

List AF, Sun Z, Verma A, Bennett JM, Komrokji RS, McGraw K, Maciejewski J, Altman JK, Cheema PS, Claxton DF, Luger SM, Mattison RJ, Wassenaar TR, Artz AS, Schiffer CA, Litzow MR, Tallman MS

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2021 March 2039 (9):1001-1009. Epub 01/13/2021.

Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Bernard E, Nannya Y, Hasserjian RP, Devlin SM, Tuechler H, Medina-Martinez JS, Yoshizato T, Shiozawa Y, Saiki R, Malcovati L, Levine MF, Arango JE, Zhou Y, Solé F, Cargo CA, Haase D, Creignou M, Germing U, Zhang Y, Gundem G, Sarian A, van de Loosdrecht AA, Jädersten M, Tobiasson M, Kosmider O, Follo MY, Thol F, Pinheiro RF, Santini V, Kotsianidis I, Boultwood J, Santos FPS, Schanz J, Kasahara S, Ishikawa T, Tsurumi H, Takaori-Kondo A, Kiguchi T, Polprasert C, Bennett JM, Klimek VM, Savona MR, Belickova M, Ganster C, Palomo L, Sanz G, Ades L, Della Porta MG, Smith AG, Werner Y, Patel M, Viale A, Vanness K, Neuberg DS, Stevenson KE, Menghrajani K, Bolton KL, Fenaux P, Pellagatti A, Platzbecker U, Heuser M, Valent P, Chiba S, Miyazaki Y, Finelli C, Voso MT, Shih LY, Fontenay M, Jansen JH, Cervera J, Atsuta Y, Gattermann N, Ebert BL, Bejar R, Greenberg PL, Cazzola M, Hellström-Lindberg E, Ogawa S, Papaemmanuil E

Nature medicine.. 2021 March 27 (3):562. Epub 1900 01 01.

A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation

Lipof JJ, Huselton EJ, Zent CS, Evans AG, Zhang B, Rothberg PG and Bennett JM.

Case Reports in Hematology. 2021; 2021(Article ID 5574766).

A Case of Acute Eosinophilic Leukemia with a Novel 6 Mutation.

Lipof JJ, Huselton EJ, Zent CS, Evans A, Zhang B, Rothberg PG, Bennett JM

Case reports in hematology.. 2021 2021 :5574766. Epub 07/03/2021.

Remission of anti-TIF1? dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome.

Bawany F, Tbakhi B, Mendler JH, Richardson CT, Bennett JM, Aljitawi OS

Blood advances.. 2020 November 244 (22):5698-5701. Epub 1900 01 01.

The role of eosinophil morphology in distinguishing between reactive eosinophilia and eosinophilia as a feature of a myeloid neoplasm.

Goasguen JE, Bennett JM, Bain BJ, Brunning R, Zini G, Vallespi MT, Tomonaga M, Locher C,

British journal of haematology.. 2020 November 191 (3):497-504. Epub 08/29/2020.

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Bernard E, Nannya Y, Hasserjian RP, Devlin SM, Tuechler H, Medina-Martinez JS, Yoshizato T, Shiozawa Y, Saiki R, Malcovati L, Levine MF, Arango JE, Zhou Y, Solé F, Cargo CA, Haase D, Creignou M, Germing U, Zhang Y, Gundem G, Sarian A, van de Loosdrecht AA, Jädersten M, Tobiasson M, Kosmider O, Follo MY, Thol F, Pinheiro RF, Santini V, Kotsianidis I, Boultwood J, Santos FPS, Schanz J, Kasahara S, Ishikawa T, Tsurumi H, Takaori-Kondo A, Kiguchi T, Polprasert C, Bennett JM, Klimek VM, Savona MR, Belickova M, Ganster C, Palomo L, Sanz G, Ades L, Della Porta MG, Smith AG, Werner Y, Patel M, Viale A, Vanness K, Neuberg DS, Stevenson KE, Menghrajani K, Bolton KL, Fenaux P, Pellagatti A, Platzbecker U, Heuser M, Valent P, Chiba S, Miyazaki Y, Finelli C, Voso MT, Shih LY, Fontenay M, Jansen JH, Cervera J, Atsuta Y, Gattermann N, Ebert BL, Bejar R, Greenberg PL, Cazzola M, Hellström-Lindberg E, Ogawa S, Papaemmanuil E

Nature medicine.. 2020 October 26 (10):1549-1556. Epub 08/03/2020.

Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes.

Melody M, Al Ali N, Zhang L, Ramadan H, Padron E, Sallman D, Sweet K, Lancet J, List A, Bennett JM, Komrokji R

Clinical lymphoma, myeloma & leukemia.. 2020 May 20 (5):324-328. Epub 01/14/2020.

A case of Burkitt Leukemia: Revisiting the prognostic value of lactate dehydrogenase.

Bodrog A, Zhang B, Liu L, Casulo C, Bennett JM

Leukemia research.. 2020 February 89 :106295. Epub 12/28/2019.

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.

Valent P, Orazi A, Savona MR, Patnaik MM, Onida F, van de Loosdrecht AA, Haase D, Haferlach T, Elena C, Pleyer L, Kern W, Pemovska T, Vladimer GI, Schanz J, Keller A, Lübbert M, Lion T, Sotlar K, Reiter A, De Witte T, Pfeilstöcker M, Geissler K, Padron E, Deininger M, Orfao A, Horny HP, Greenberg PL, Arber DA, Malcovati L, Bennett JM

Haematologica.. 2019 October 104 (10):1935-1949. Epub 05/02/2019.

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900.

Fernandez HF, Sun Z, Litzow MR, Luger SM, Paietta E, Racevskis J, Levine RL, Patel JP, Abdel-Wahab O, Ketterling RP, Dewald GW, Bennett JM, Rowe JM, Lazarus HM, Tallman MS

Haematologica.. 2019 April 104 (4):e147-e150. Epub 11/22/2018.

Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.

Neukirchen-Strapatsas J, Tuechler H, Porta MD, Fenaux P, Guerci A, Haas R, Rossi M, Sapena R, Sperr WR, Strupp C, Stamatoullas A, Valent P, Germing U, Bennett JM

Leukemia research.. 2019 February 77 :8-13. Epub 12/28/2018.

Hemophagocytic Lymphohistiocytosis in a Patient With Multiple Myeloma.

Hsu CM, Bennett JM, Lipe B

Clinical lymphoma, myeloma & leukemia.. 2019 January 19 (1):e29-e32. Epub 09/05/2018.

Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.

Schanz J, Solé F, Mallo M, Luño E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D

Genes, chromosomes & cancer.. 2018 November 57 (11):547-556. Epub 09/24/2018.

Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia.

Hudson CA, Burack WR, Bennett JM

Leukemia research.. 2018 October 73 :12-15. Epub 08/28/2018.

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS.

Miyazaki Y, Tuechler H, Sanz G, Schanz J, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Santini V, Lübbert M, Maciejewski J, Machherndl-Spandl S, Magalhaes SMM, Pfeilstöcker M, Sekeres MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D, Greenberg PL

Leukemia research.. 2018 October 73 :51-57. Epub 09/06/2018.

Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia.

Hudson CA, Burack WR, Leary PC, Bennett JM

American journal of clinical pathology.. 2018 August 30150 (4):293-302. Epub 1900 01 01.

Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.

Ganzel C, Sun Z, Cripe LD, Fernandez HF, Douer D, Rowe JM, Paietta EM, Ketterling R, O'Connell MJ, Wiernik PH, Bennett JM, Litzow MR, Luger SM, Lazarus HM, Tallman MS

American journal of hematology.. 2018 August 93 (8):1074-1081. Epub 1900 01 01.

Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.

Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespi MT, Tomonaga M, Zini G, Renault A,

British journal of haematology.. 2018 August 182 (4):526-533. Epub 06/19/2018.

Morphologic dysplasia in Myelodysplastic Syndromes: How accurate are morphologists?

Bennett JM

Leukemia research.. 2018 August 71 :34-35. Epub 06/21/2018.

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions.

Valent P, Orazi A, Steensma DP, Ebert BL, Haase D, Malcovati L, van de Loosdrecht AA, Haferlach T, Westers TM, Wells DA, Giagounidis A, Loken M, Orfao A, Lübbert M, Ganser A, Hofmann WK, Ogata K, Schanz J, Béné MC, Hoermann G, Sperr WR, Sotlar K, Bettelheim P, Stauder R, Pfeilstöcker M, Horny HP, Germing U, Greenberg P, Bennett JM

Oncotarget.. 2017 September 268 (43):73483-73500. Epub 07/05/2017.

New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types.

Strupp C, Nachtkamp K, Hildebrandt B, Giagounidis A, Haas R, Gattermann N, Bennett JM, Aul C, Germing U

Leukemia research.. 2017 June 57 :78-84. Epub 02/27/2017.

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Greenberg PL, Stone RM, Al-Kali A, Barta SK, Bejar R, Bennett JM, Carraway H, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Horsfall R, Johnson RA, Juckett M, Klimek VM, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Shami PJ, Stein BL, Walker AR, Westervelt P, Zeidan A, Shead DA, Smith C

Journal of the National Comprehensive Cancer Network : JNCCN.. 2017 January 15 (1):60-87. Epub 1900 01 01.

Who Has Therapy-Related AML?

Gale RP, Bennett JM, Hoffman FO

Mediterranean journal of hematology and infectious diseases.. 2017 9 (1):e2017025. Epub 03/01/2017.

Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms.

Bennett JM

Clinical lymphoma, myeloma & leukemia.. 2016 November 16 (11):607-609. Epub 08/12/2016.

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes.

Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D

Blood.. 2016 October 20128 (16):2096-2097. Epub 08/17/2016.

Time-dependent changes in mortality and transformation risk in MDS.

Pfeilstöcker M, Tuechler H, Sanz G, Schanz J, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Levis A, Luebbert M, Maciejewski J, Machherndl-Spandl S, Magalhaes SM, Miyazaki Y, Sekeres MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, Van de Loosdrecht AA, Germing U, Haase D, Greenberg PL

Blood.. 2016 August 18128 (7):902-10. Epub 06/22/2016.

Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?).

Bennett JM, Tuechler H, Aul C, Strupp C, Germing U

Leukemia research.. 2016 August 47 :63-9. Epub 05/12/2016.

Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia.

Goasguen JE, Bennett JM, Bain BJ, Brunning RD, Vallespí MT, Tomonaga M, Zini G, Renault A,

Leukemia research.. 2016 June 45 :75-81. Epub 04/11/2016.

T-cell large granular lymphocyte proliferation in myelodysplastic syndromes: Clinicopathological features and prognostic significance.

Zhang X, Sokol L, Bennett JM, Moscinski LC, List A, Zhang L

Leukemia research.. 2016 April 43 :18-23. Epub 02/17/2016.

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups.

Luskin MR, Lee JW, Fernandez HF, Abdel-Wahab O, Bennett JM, Ketterling RP, Lazarus HM, Levine RL, Litzow MR, Paietta EM, Patel JP, Racevskis J, Rowe JM, Tallman MS, Sun Z, Luger SM

Blood.. 2016 March 24127 (12):1551-8. Epub 01/11/2016.

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.

Braulke F, Müller-Thomas C, Götze K, Platzbecker U, Germing U, Hofmann WK, Giagounidis AA, Lübbert M, Greenberg PL, Bennett JM, Solé F, Slovak ML, Ohyashiki K, Le Beau MM, Tüchler H, Pfeilstöcker M, Hildebrandt B, Aul C, Stauder R, Valent P, Fonatsch C, Bacher U, Trümper L, Haase D, Schanz J

Genes, chromosomes & cancer.. 2015 December 54 (12):809-17. Epub 09/10/2015.

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS.

List AF, Bennett JM, Sekeres MA, Skikne B, Fu T, Shammo JM, Nimer SD, Knight RD, Giagounidis A

Leukemia.. 2015 December 29 (12):2452. Epub 1900 01 01.

Re: Lee H, et al. An unusual case of myeloperoxidase-positive acute megakaryoblastic leukemia. Ann Lab Med 2015;35:466-8.

Bennett JM, Wells DA

Annals of laboratory medicine.. 2015 September 35 (5):542-3. Epub 1900 01 01.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA

Mayo Clinic proceedings.. 2015 August 90 (8):996-1000. Epub 07/23/2015.

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).

Porta MG, Tuechler H, Malcovati L, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D, Greenberg PL, Cazzola M

Leukemia.. 2015 July 29 (7):1502-13. Epub 02/27/2015.

Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998).

Loughran TP, Zickl L, Olson TL, Wang V, Zhang D, Rajala HL, Hasanali Z, Bennett JM, Lazarus HM, Litzow MR, Evens AM, Mustjoki S, Tallman MS

Leukemia.. 2015 April 29 (4):886-94. Epub 09/13/2014.

Myelodysplastic syndromes, version 2.2015.

Greenberg PL, Stone RM, Bejar R, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Klimek V, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Scott B, Shami PJ, Stein BL, Westervelt P, Wheeler B, Shead DA, Smith C

Journal of the National Comprehensive Cancer Network : JNCCN.. 2015 March 13 (3):261-72. Epub 1900 01 01.

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.

Braulke F, Platzbecker U, Müller-Thomas C, Götze K, Germing U, Brümmendorf TH, Nolte F, Hofmann WK, Giagounidis AA, Lübbert M, Greenberg PL, Bennett JM, Sole' F, Mallo M, Slovak ML, Ohyashiki K, Le Beau MM, Tüchler H, Pfeilstöcker M, Nösslinger T, Hildebrandt B, Shirneshan K, Aul C, Stauder R, Sperr WR, Valent P, Fonatsch C, Trümper L, Haase D, Schanz J

Haematologica.. 2015 February 100 (2):205-13. Epub 10/24/2014.

Therapy-Related AML and MDS: Who Really Has It? The Hematologist ASH News and Reports.

Gale RP, Bennett JM, Hoffman FO.

ASH News and Reports. 2015; Volume 12 Issue 4.

A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution.

Peker D, Padron E, Bennett JM, Zhang X, Horna P, Epling-Burnette PK, Lancet JE, Pinilla-Ibarz J, Moscinski L, List AF, Komrokji RS, Zhang L

Acta haematologica.. 2015 133 (2):249-56. Epub 11/20/2014.

"Preleukemic or smoldering" chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report.

Bennett JM, Dsouza KG, Patel M, O'Dwyer K

Leukemia research reports.. 2015 4 (1):12-4. Epub 12/19/2014.

Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.

Lucas DM, Stark A, Lozanski G, Dewald GW, Lozanski A, Claus R, Plass C, Flinn IW, Neuberg DS, Paietta EM, Bennett JM, Jelinek DF, Gribben JG, Hussein MA, Appelbaum FR, Larson RA, Moore DF, Tallman MS, Byrd JC, Grever MR

Leukemia & lymphoma.. 2015 56 (11):3031-7. Epub 03/30/2015.

Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q).

Sekeres MA, Swern AS, Fenaux P, Greenberg PL, Sanz GF, Bennett JM, Dreyfus F, List AF, Li JS, Sugrue MM

Blood cancer journal.. 2014 August 294 (8):e242. Epub 08/29/2014.

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS.

List AF, Bennett JM, Sekeres MA, Skikne B, Fu T, Shammo JM, Nimer SD, Knight RD, Giagounidis A

Leukemia.. 2014 May 28 (5):1033-40. Epub 10/22/2013.

Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes.

Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespi MT, Tomonaga M, Zini G, Renault A,

Leukemia research.. 2014 April 38 (4):447-53. Epub 12/29/2013.

Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes.

Seymour JF, Bennett JM, List AF, Mufti GJ, Gore SD, Fenaux P, Santini V, Hetzer J, Songer S, Skikne BS, Beach CL

British journal of haematology.. 2014 April 165 (1):49-56. Epub 01/28/2014.

Therapy-related AML: a slip of the lip can sink a ship.

Gale RP, Bennett JM, Hoffman FO

Leukemia research.. 2014 March 38 (3):418-20. Epub 01/05/2014.

Extracellular crystals in plasma cell myeloma.

Brown JT, Burack WR, Becker MW, Vlad-Vonica R, Nadasdy T, Bennett JM, Mendler JH

Leukemia research reports.. 2014 3 (2):49-50. Epub 06/18/2014.

Concurrence of B-lymphoblastic leukemia and myeloproliferative neoplasm with copy neutral loss of heterozygosity at chromosome 1p harboring a MPL W515S mutation.

Tao J, Zhang X, Lancet J, Bennett JM, Cai L, Papenhausen P, Moscinski L, Zhang L

Cancer genetics.. 2014 207 (10-12):489-94. Epub 10/13/2014.

The myelodysplastic syndromes: a personal recollection of four decades of classification and prognostic scoring systems.

Bennett JM

Leukemia & lymphoma.. 2013 December 54 (12):2588-91. Epub 05/07/2013.

Current pathology practices in and barriers to MDS diagnosis.

Glauser TA, Sagatys EM, Williamson JC, Burton BS, Berger C, Merwin P, Sugrue M, Bennett JM

Leukemia research.. 2013 December 37 (12):1656-61. Epub 10/22/2013.

Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.

Mailloux AW, Zhang L, Moscinski L, Bennett JM, Yang L, Yoder SJ, Bloom G, Wei C, Wei S, Sokol L, Loughran TP, Epling-Burnette PK

The Journal of immunology : official journal of the American Association of Immunologists.. 2013 October 1191 (7):3578-93. Epub 09/06/2013.

Monosomal karyotype in MDS: explaining the poor prognosis?

Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, Grau J, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D

Leukemia.. 2013 October 27 (10):1988-95. Epub 06/21/2013.

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial.

Gore SD, Fenaux P, Santini V, Bennett JM, Silverman LR, Seymour JF, Hellstrom-Lindberg E, Swern AS, Beach CL, List AF

Haematologica.. 2013 July 98 (7):1067-72. Epub 04/12/2013.

Myelodysplastic syndromes: clinical practice guidelines in oncology.

Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, Frankfurt O, Gaensler K, Garcia-Manero G, Gore SD, Head D, Komrokji R, Maness LJ, Millenson M, O'Donnell MR, Shami PJ, Stein BL, Stone RM, Thompson JE, Westervelt P, Wheeler B, Shead DA, Naganuma M

Journal of the National Comprehensive Cancer Network : JNCCN.. 2013 July 11 (7):838-74. Epub 1900 01 01.

Morphological classification of the myelodysplastic syndromes: how much more education of diagnosticians is necessary?

Bennett JM

Haematologica.. 2013 April 98 (4):490-1. Epub 1900 01 01.

Hemophagocytic lymphohistiocytosis masquerading as progressive chronic lymphocytic leukemia.

Kilari D, Venci N, Friedberg J, Bennett JM

Leukemia research reports.. 2013 2 (1):4-6. Epub 01/05/2013.

Revised international prognostic scoring system for myelodysplastic syndromes.

Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D

Blood.. 2012 September 20120 (12):2454-65. Epub 06/27/2012.

Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.

Reid R, Bennett JM, Becker M, Chen Y, Milner L, Phillips Ii GL, Liesveld J

American journal of hematology.. 2012 July 87 (7):743-5. Epub 05/10/2012.

Leukemia Research welcomes a new co-editor-in-chief: Eric J. Feldman, M.D.

Bennett JM

Leukemia research.. 2012 June 36 (6):663. Epub 04/12/2012.

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Garcia-Manero G, Faderl S, Pierce S, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2012 March 1030 (8):820-9. Epub 02/13/2012.

Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.

Mathew RA, Bennett JM, Liu JJ, Komrokji RS, Lancet JE, Naghashpour M, Messina JL, List AF, Moscinski LC, Zhang L

Leukemia research.. 2012 January 36 (1):72-80. Epub 07/22/2011.

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, Liesveld J, Ryan DH, Richard Burack W, Bennett JM

Leukemia research.. 2012 January 36 (1):81-6. Epub 09/03/2011.

Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS.

Valent P, Bain BJ, Bennett JM, Wimazal F, Sperr WR, Mufti G, Horny HP

Leukemia research.. 2012 January 36 (1):1-5. Epub 09/13/2011.

A Tribute to Professor Terence "Terry" John Hamblin.

Bennett JM.

Leuk. Res. 2012; 36(4): 383-384.

Myelodysplastic Syndromes: Revised Prognostic Scoring System.

Bennett JM.

Turk Hemat. Soc. Congress. 2012; : 115-118.

Plastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

Raul MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov NN, Burack WRBennett JM.

Leuk. Res. 2012; Jan.(36(1)): 81-6.

A Tribute to Professor Terence "Terry" John Hamblin.

Bennett JM.

Leuk Res. 2012; 36(4): 383-384.

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

Smith MR, Neuberg D, Flinn IW, Grever MR, Lazarus HM, Rowe JM, Dewald G, Bennett JM, Paietta EM, Byrd JC, Hussein MA, Appelbaum FR, Larson RA, Litzow MR, Tallman MS

Blood.. 2011 September 29118 (13):3525-7. Epub 07/29/2011.

Uncommon of the uncommon: low-grade myelodysplastic syndrome evolving into chronic myelogenous leukemia.

Zhang L, Bennett JM, Zhang X, Moscinski L, Ibarz-Pinilla J, List AF, Komrokji R

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2011 May 2029 (15):e434-6. Epub 12/13/2010.

The Myelodysplastic Syndromes (MDS) Foundation: a retrospective analysis of a nonprofit foundation.

Bennett JM, Hamblin TJ, Mufti GJ

Leukemia research.. 2011 March 35 (3):283-5. Epub 10/23/2010.

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.

Greenberg PL, Attar E, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Foran JM, Gaensler K, Garcia-Manero G, Gore SD, Head D, Komrokji R, Maness LJ, Millenson M, Nimer SD, O'Donnell MR, Schroeder MA, Shami PJ, Stone RM, Thompson JE, Westervelt P

Journal of the National Comprehensive Cancer Network : JNCCN.. 2011 January 9 (1):30-56. Epub 1900 01 01.

Cancer and the older patient: Let's waltz together.

Bennett JM.

J. Geriatr Oncol. 2011; 2(4): 274-5.

Let's waltz together.

Bennett JM.

J Geriatr Oncol. 2011; 2: 274-275.

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.

Tallman MS, Kim HT, Montesinos P, Appelbaum FR, de la Serna J, Bennett JM, Deben G, Bloomfield CD, Gonzalez J, Feusner JH, Gonzalez M, Gallagher R, Miguel JD, Larson RA, Milone G, Paietta E, Rayon C, Rowe JM, Rivas C, Schiffer CA, Vellenga E, Shepherd L, Slack JL, Wiernik PH, Willman CL, Sanz MA

Blood.. 2010 December 16116 (25):5650-9. Epub 09/21/2010.

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.

Cripe LD, Uno H, Paietta EM, Litzow MR, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Luger S, Tallman MS

Blood.. 2010 November 18116 (20):4077-85. Epub 08/17/2010.

Is the association of "cup-like" nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful?

Bennett JM, Pryor J, Laughlin TS, Rothberg PG, Burack WR

American journal of clinical pathology.. 2010 October 134 (4):648-52. Epub 1900 01 01.

Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia.

Allen SL, Kolitz JE, Lundberg AS, Bennett JM, Capizzi RL, Budman DR

Leukemia research.. 2010 April 34 (4):487-91. Epub 09/12/2009.

Myelodysplastic syndromes classification and risk stratification.

Komrokji RS, Zhang L, Bennett JM

Hematology/oncology clinics of North America.. 2010 April 24 (2):443-57. Epub 1900 01 01.

Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group.

Litzow MR, Othus M, Cripe LD, Gore SD, Lazarus HM, Lee SJ, Bennett JM, Paietta EM, Dewald GW, Rowe JM, Tallman MS,

British journal of haematology.. 2010 January 148 (2):217-25. Epub 10/05/2009.

Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.

Wiernik PH, Hong F, Glick JH, Bennett JM

Leukemia & lymphoma.. 2009 October 50 (10):1632-41. Epub 1900 01 01.

Anthracycline dose intensification in acute myeloid leukemia.

Fernandez HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM, Racevskis J, Dewald GW, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Tallman MS

The New England journal of medicine.. 2009 September 24361 (13):1249-59. Epub 1900 01 01.

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

Greenberg PL, Sun Z, Miller KB, Bennett JM, Tallman MS, Dewald G, Paietta E, van der Jagt R, Houston J, Thomas ML, Cella D, Rowe JM

Blood.. 2009 September 17114 (12):2393-400. Epub 06/29/2009.

WITHDRAWN: Enhancing geriatric oncology training to care for elders: A clinical initiative with long-term follow-up.

Bennett JM, Hall WJ, Sahasrabudhe D, Balducci L

Critical reviews in oncology/hematology.. 2009 August 8 Epub 08/08/2009.

Morphological evaluation of monocytes and their precursors.

Goasguen JE, Bennett JM, Bain BJ, Vallespi T, Brunning R, Mufti GJ,

Haematologica.. 2009 July 94 (7):994-7. Epub 06/16/2009.

Therapy related CMML: a case report and review of the literature.

Ahmed F, Osman N, Lucas F, Neff G, Smolarek T, Bennett JM, Komrokji RS

International journal of hematology.. 2009 June 89 (5):699-703. Epub 05/09/2009.

Are myelodysplastic syndromes and acute myeloid leukemia one disease?

Gale RP, Bennett JM

Leukemia research.. 2009 March 33 (3):351-4. Epub 11/08/2008.

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR,

The Lancet. Oncology.. 2009 March 10 (3):223-32. Epub 02/21/2009.

Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.

Bennett JM, Orazi A

Haematologica.. 2009 February 94 (2):264-8. Epub 01/14/2009.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.

Oliansky DM, Antin JH, Bennett JM, Deeg HJ, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Jones RB, McCarthy PL, Hahn T

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2009 February 15 (2):137-72. Epub 1900 01 01.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes.

Oliansky DM, Antin JH, Bennett JM, Deeg JH, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Johes RB, McCarthy Pl,Jr, Hahn T.

Biol. Blood Marrow Transplant. 2009; 15(2): 137-172.

Consensus statement on iron overload in myelodysplastic syndromes.

Bennett JM,

American journal of hematology.. 2008 November 83 (11):858-61. Epub 1900 01 01.

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.

Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, Cazzola M, Fenaux P, Germing U, Hellström-Lindberg E, Jinnai I, Manabe A, Matsuda A, Niemeyer CM, Sanz G, Tomonaga M, Vallespi T, Yoshimi A,

Haematologica.. 2008 November 93 (11):1712-7. Epub 10/06/2008.

Myelodysplastic syndromes.

Greenberg PL, Attar E, Battiwalla M, Bennett JM, Bloomfield CD, DeCastro CM, Deeg HJ, Erba HP, Foran JM, Garcia-Manero G, Gore SD, Head D, Maness LJ, Millenson M, Nimer SD, O'Donnell MR, Saba HI, Shami PJ, Spiers K, Stone RM, Tallman MS, Westervelt P,

Journal of the National Comprehensive Cancer Network : JNCCN.. 2008 October 6 (9):902-26. Epub 1900 01 01.

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

Kantarjian H, O'Brien S, Ravandi F, Cortes J, Shan J, Bennett JM, List A, Fenaux P, Sanz G, Issa JP, Freireich EJ, Garcia-Manero G

Cancer.. 2008 September 15113 (6):1351-61. Epub 1900 01 01.

Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.

Germing U, Aul C, Niemeyer CM, Haas R, Bennett JM

Annals of hematology.. 2008 September 87 (9):691-9. Epub 06/25/2008.

Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey.

Steensma DP, Heptinstall KV, Johnson VM, Novotny PJ, Sloan JA, Camoriano JK, Niblack J, Bennett JM, Mesa RA

Leukemia research.. 2008 May 32 (5):691-8. Epub 12/04/2007.

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, Dreisbach L, Schiffer CA, Stone RM, Greenberg PL, Curtin PT, Klimek VM, Shammo JM, Thomas D, Knight RD, Schmidt M, Wride K, Zeldis JB, List AF

Blood.. 2008 January 1111 (1):86-93. Epub 09/24/2007.

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

Guzman ML, Rossi RM, Neelakantan S, Li X, Corbett CA, Hassane DC, Becker MW, Bennett JM, Sullivan E, Lachowicz JL, Vaughan A, Sweeney CJ, Matthews W, Carroll M, Liesveld JL, Crooks PA, Jordan CT

Blood.. 2007 December 15110 (13):4427-35. Epub 09/05/2007.

Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.

Wimazal F, Fonatsch C, Thalhammer R, Schwarzinger I, Müllauer L, Sperr WR, Bennett JM, Valent P

Leukemia research.. 2007 November 31 (11):1461-8. Epub 05/16/2007.

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma.

Roboz GJ, Bennett JM, Coleman M, Ritchie EK, Furman RR, Rossi A, Jhaveri K, Feldman EJ, Leonard JP

Leukemia research.. 2007 August 31 (8):1141-4. Epub 05/01/2007.

Chronic myelomonocytic leukemia in the light of the WHO proposals.

Germing U, Strupp C, Knipp S, Kuendgen A, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N, Bennett JM

Haematologica.. 2007 July 92 (7):974-7. Epub 1900 01 01.

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.

Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, Loken M, van de Loosdrecht A, Ogata K, Orfao A, Pfeilstöcker M, Rüter B, Sperr WR, Stauder R, Wells DA

Leukemia research.. 2007 June 31 (6):727-36. Epub 01/25/2007.

Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond--9th European Hematology Association Congress Geneva, Switzerland, 10-13 June 2004.

Fenaux P, Bennett JM, Bowen DT, Knight RD, List AF

Transfusion medicine.. 2007 June 17 (3):151-60. Epub 1900 01 01.

Organization of the clinical activity of geriatric oncology: report of a SIOG (International Society of Geriatric Oncology) task force.

Monfardini S, Aapro MS, Bennett JM, Mori M, Regenstreif D, Rodin M, Stein B, Zulian GB, Droz JP

Critical reviews in oncology/hematology.. 2007 April 62 (1):62-73. Epub 02/14/2007.

Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.

Flinn IW, Neuberg DS, Grever MR, Dewald GW, Bennett JM, Paietta EM, Hussein MA, Appelbaum FR, Larson RA, Moore DF, Tallman MS

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2007 March 125 (7):793-8. Epub 02/05/2007.

Evolving classifications of the myelodysplastic syndromes.

Komrokji RS, Bennett JM

Current opinion in hematology.. 2007 March 14 (2):98-105. Epub 1900 01 01.

Aging, cancer, and anemia: intertwined and resolvable.

Bennett JM

The journal of supportive oncology.. 2007 March 5 (3):116-7. Epub 1900 01 01.

The third International Congress on Myeloproliferative and Myelodysplastic Syndromes.

Silver RT, Bennett JM, Goldman JM, Spivak JL, Tefferi A

Leukemia research.. 2007 January 31 (1):11-7. Epub 04/18/2006.

A Tribute to Professor David A. G. Galton.

Bain B, Bennett JM, Catovsky D, Flandrin G.

Leuk. Res. 2007; 31(7): 889-890.

Blood Morphology: The latest revisions of the diagnosis of the Myelodysplastic Syndromes (F.A.B./W.H.O.) - 2007.

Bennett JM.

Sysmex Journal International. 2007; 17.

MDS: Molecular Biology, Pathology, and Cytogenetics.

Komrokji R, Bennett JM.

McGraw Hill. 2007; 38: 367-376.

A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.

Litzow MR, Lee S, Bennett JM, Dewald GW, Gallagher RE, Jain V, Paietta EM, Racevskis J, Rousey SR, Mazza JJ, Tallman MS

Haematologica.. 2006 August 91 (8):1105-8. Epub 07/25/2006.

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.

Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H

Blood.. 2006 July 15108 (2):419-25. Epub 04/11/2006.

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.

Slovak ML, Gundacker H, Bloomfield CD, Dewald G, Appelbaum FR, Larson RA, Tallman MS, Bennett JM, Stirewalt DL, Meshinchi S, Willman CL, Ravindranath Y, Alonzo TA, Carroll AJ, Raimondi SC, Heerema NA

Leukemia.. 2006 July 20 (7):1295-7. Epub 04/20/2006.

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.

Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, Klimek V, Slack J, de Castro C, Ravandi F, Helmer R, Shen L, Nimer SD, Leavitt R, Raza A, Saba H

Cancer.. 2006 April 15106 (8):1794-803. Epub 1900 01 01.

Who is WHO in myelodysplastic syndromes? Clinical implications of the WHO classification.

Komrokji RS, Bennett JM

Current hematologic malignancy reports.. 2006 March 1 (1):9-15. Epub 1900 01 01.

Comment on flow-cytometric analysis of neutrophils.

Bennett JM

American journal of hematology.. 2006 February 81 (2):155. Epub 1900 01 01.

Myelodysplastic syndromes clinical practice guidelines in oncology.

Greenberg PL, Baer MR, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Devetten MP, Emanuel PD, Erba HP, Estey E, Foran J, Gore SD, Millenson M, Navarro WH, Nimer SD, O'Donnell MR, Saba HI, Spiers K, Stone RM, Tallman MS

Journal of the National Comprehensive Cancer Network : JNCCN.. 2006 January 4 (1):58-77. Epub 1900 01 01.

The myelodysplastic syndromes: diagnosis and treatment.

Steensma DP, Bennett JM

Mayo Clinic proceedings.. 2006 January 81 (1):104-30. Epub 1900 01 01.

Clinical application and proposal for modification of the international working group (IWG) response criteria in myelodysplasia

Cheson,B. D.; Greenberg,P. L.; Bennett,J. M.; Lowenberg,B.; Wijermans,P. W.; Nimer,S. D.; Pinto,A.; Beran,M.; de Witte,T. M.; Stone,R. M.; Mittelman,M.; Sanz,G. F.; Gore,S. D.; Schiffer,C. A.; Kantarjian,H.;.

Blood. 2006; .

The third international congress on myeloproliferative and myelodysplastic syndromes

Silver,R. T.; Bennett,J. M.; Goldman,J. M.; Spivak,J. L.; Tefferi,A.;.

Leukemia research. 2006; .

Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology.

Greenberg PL, Baer MR, Bennett JM, Bloomfield CD, DeCastro CM, Deeg HJ, Devetten MP, Emanuel PD, Erba HP, Estey E, Foran J, Gore SD, Millenson M, Navarro WH, Nimer SD, ODonnell MR, Saba HI, Spiers K, Stone RM, Tallman MS.

Journal National Comprehensive Cancer Network. 2006; .

Phase II Trial of Subcutaneous Recombinant Human Interleukin 11 with Subcutaneous Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Patients with Acute Myeloid Leukemia (AML) Receiving High-Dose Cytarabine During Induction: ECOG 3997.

Cripe Larry D, Rader Kevin S, Tallman Martin S, Gordon Michael S, Paietta Elisabeth, Bennett John M, Neuberg Donna S, Litzow Mark R, OBrien Timothy E, Rowe Jacob M.

Leukemia Research. 2006; .

Lenalidomide in Myelodysplastic Syndrome awith Chromosome 5q Deletion.

List A, Dewald G, Bennett JM, Giagounadis A, Raza A, Feldman E, Powell B, Greenberg P, Thomas D, Reeder C, Wride K, Patin J, Schmidt M, Zeldis J, Knight R, and the MDS-003 Study Investigators.

The New England Journal of Medicine. 2006; : 1456-1465.

A Comparative Review of Classification Systems in MDS.

Bennett JM.

Semin Oncol. 2006; 4(5): 3-10.

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.

Larson RA, Sievers EL, Stadtmauer EA, Löwenberg B, Estey EH, Dombret H, Theobald M, Voliotis D, Bennett JM, Richie M, Leopold LH, Berger MS, Sherman ML, Loken MR, van Dongen JJ, Bernstein ID, Appelbaum FR

Cancer.. 2005 October 1104 (7):1442-52. Epub 1900 01 01.

A comparative review of classification systems in myelodysplastic syndromes (MDS).

Bennett JM

Seminars in oncology.. 2005 August 32 (4 Suppl 5):S3-10. Epub 1900 01 01.

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

Bennett JM, Kaminski MS, Leonard JP, Vose JM, Zelenetz AD, Knox SJ, Horning S, Press OW, Radford JA, Kroll SM, Capizzi RL

Blood.. 2005 June 15105 (12):4576-82. Epub 02/24/2005.

The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.

Komrokji RS, Bennett JM

Current hematology reports. 2005 May 4 (3):175-81. Epub 1900 01 01.

Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).

Dutcher JP, Lee S, Gallagher RE, Makary AZ, Hines JD, Londer H, Farnen JP, Bennett JM, Paietta E, Rowe JM, Goloubeva O, Wiernik PH,

Leukemia & lymphoma.. 2005 March 46 (3):377-85. Epub 1900 01 01.

Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).

Cassileth PA, Lee SJ, Litzow MR, Miller KB, Stadtmauer EA, Tallman MS, Lazarus HM, Bennett JM, Paietta E, Dewald GW, Rowe JM,

Leukemia & lymphoma.. 2005 January 46 (1):55-61. Epub 1900 01 01.

The Clincial Implications of the World Health Organizations Classification of Myelodysplastic Syndromes.

Bennett JM.

Current Medicine. 2005; .

Response to Letter of the Editor.

Bennett, JM.

Cancer Genetics and Cytogenetics. 2005; 162(1).

A Phase II Trial of Arsenic Trioxide for Relapsed and Refractory Acute Lymphoblastic Leukemia

Litzow Mark R, Lee Sandra, Bennett JM, Dewald Gordon, Gallagher RE, Jain Vibha, Paietta Elisabeth E, Racevskis Janis, Rousey Steven R, Mazza Joseph J, Tallman Martin S.

Leukemia Research. 2005; .

Introduction to the Special Issue on Geriatric Oncology.

Bennett JM, Hall WJ.

The Cancer Journal. 2005; 11(6): 435-436.

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment.

Bennett JM, Komrokji RS

Hematology.. 2005 10 Suppl 1 :258-69. Epub 1900 01 01.

Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998).

Wiernik PH, Paietta E, Goloubeva O, Lee SJ, Makower D, Bennett JM, Wade JL, Ghosh C, Kaminer LS, Pizzolo J, Tallman MS,

Leukemia.. 2004 October 18 (10):1605-10. Epub 1900 01 01.

The second international congress on myeloproliferative and myelodysplastic syndromes.

Silver RT, Bennett JM, Deininger M, Feldman E, Rafii S, Silverstein RL, Solberg LA, Spivak JL

Leukemia research.. 2004 September 28 (9):979-85. Epub 1900 01 01.

Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review.

Komrokji R, Ifthikharuddin JJ, Felgar RE, Abboud CN, Wedow LA, Connaughton A, Bennett JM

American journal of hematology.. 2004 August 76 (4):389-94. Epub 1900 01 01.

Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.

Paietta E, Ferrando AA, Neuberg D, Bennett JM, Racevskis J, Lazarus H, Dewald G, Rowe JM, Wiernik PH, Tallman MS, Look AT

Blood.. 2004 July 15104 (2):558-60. Epub 03/25/2004.

A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.

Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS,

Cytometry. Part B, Clinical cytometry.. 2004 May 59 (1):1-9. Epub 1900 01 01.

Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.

Tallman MS, Kim HT, Paietta E, Bennett JM, Dewald G, Cassileth PA, Wiernik PH, Rowe JM,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2004 April 122 (7):1276-86. Epub 02/17/2004.

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

Greenberg PL, Lee SJ, Advani R, Tallman MS, Sikic BI, Letendre L, Dugan K, Lum B, Chin DL, Dewald G, Paietta E, Bennett JM, Rowe JM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2004 March 1522 (6):1078-86. Epub 1900 01 01.

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.

Rowe JM, Neuberg D, Friedenberg W, Bennett JM, Paietta E, Makary AZ, Liesveld JL, Abboud CN, Dewald G, Hayes FA, Tallman MS, Wiernik PH,

Blood.. 2004 January 15103 (2):479-85. Epub 09/25/2003.

Comment to Letter by W. G. Finn: 03-D849.

Bennett J.

Leukemia Research. 2004; 28(2): 215.

Promises and Challenges of Oncology and Hematology.

Aapro M, Bennett J, Broxmeyer H, Repetto L, Robert J, Sternberg C, Surbone A.

Critical Reviews in Oncology Hematology. 2004; 50(1).

Atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate.

Wittman B, Horan J, Baxter J, Goldberg J, Felgar R, Baylor E, Cromwell B, Cross N, Bennett JM.

Leuk. Res. 2004; 28(1): 65-69.

The peripheral blood smear clues to clinically important diseases.

Bennett Jm, Shafer JA.

Medicine. 2004; 161: 971-975.

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.

Cheson BD, Bennett JM, Kopecky KJ, Büchner T, Willman CL, Estey EH, Schiffer CA, Doehner H, Tallman MS, Lister TA, Lo-Coco F, Willemze R, Biondi A, Hiddemann W, Larson RA, Löwenberg B, Sanz MA, Head DR, Ohno R, Bloomfield CD, LoCocco F,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2003 December 1521 (24):4642-9. Epub 1900 01 01.

Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study.

Cherry AM, Brockman SR, Paternoster SF, Hicks GA, Neuberg D, Higgins RR, Bennett JM, Greenberg PL, Miller K, Tallman MS, Rowe J, Dewald GW

Leukemia research.. 2003 December 27 (12):1085-90. Epub 1900 01 01.

The myelodysplastic/myeloproliferative disorders: the interface.

Bennett JM

Hematology/oncology clinics of North America.. 2003 October 17 (5):1095-100, v. Epub 1900 01 01.

Diagnosis and treatment of systemic mastocytosis: state of the art.

Valent P, Akin C, Sperr WR, Horny HP, Arock M, Lechner K, Bennett JM, Metcalfe DD

British journal of haematology.. 2003 September 122 (5):695-717. Epub 1900 01 01.

Morphological and cytochemical characteristics of leukaemic promyelocytes.

Liso V, Bennett J

Best practice & research. Clinical haematology.. 2003 September 16 (3):349-55. Epub 1900 01 01.

A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).

Wiernik PH, Cassileth PA, Leong T, Hoagland HC, Bennett JM, Paietta E, Oken MM,

Leukemia & lymphoma.. 2003 September 44 (9):1515-21. Epub 1900 01 01.

Morphologic dysplasia in acute myeloid leukemia: importance of granulocytic dysplasia.

Bennett JM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2003 August 121 (15):3004; author reply 3004-5. Epub 1900 01 01.

Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials.

Paietta E, Neuberg D, Bennett JM, Dewald G, Rowe JM, Cassileth PA, Cripe L, Tallman MS, Wiernik PH,

Leukemia.. 2003 August 17 (8):1544-50. Epub 1900 01 01.

Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group.

Radin AI, Kim HT, Grant BW, Bennett JM, Kirkwood JM, Stewart JA, Hahn RG, Dutcher JP, Wiernik PH, Oken MM,

Cancer.. 2003 July 198 (1):100-9. Epub 1900 01 01.

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria.

Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP, Bennett JM, Metcalfe DD

Leukemia research.. 2003 July 27 (7):635-41. Epub 1900 01 01.

Burkitt's leukemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt's leukemia/lymphoma): case report and review of literature.

Komrokji R, Lancet J, Felgar R, Wang N, Bennett JM

Leukemia research.. 2003 June 27 (6):561-6. Epub 1900 01 01.

Gender differences in old age mortality: roles of health behavior and baseline health status.

Liang J, Bennett JM, Sugisawa H, Kobayashi E, Fukaya T

Journal of clinical epidemiology.. 2003 June 56 (6):572-82. Epub 1900 01 01.

The myelodysplastic syndromes: classification and prognosis.

Komrokji R, Bennett JM

Current hematology reports. 2003 May 2 (3):179-85. Epub 1900 01 01.

Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.

Armitage JO, Carbone PP, Connors JM, Levine A, Bennett JM, Kroll S

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2003 March 121 (5):897-906. Epub 1900 01 01.

A brief commentary on "Refractory anemia with ring sideroblasts associated with i(17q) and mutation of the TP53 gene".

Bennett JM

Cancer genetics and cytogenetics.. 2003 March 141 (2):177. Epub 1900 01 01.

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.

Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, Head DR

Leukemia.. 2003 February 17 (2):277-82. Epub 1900 01 01.

Morphologic dysplasia in acute myeloid leukemia: importance of granulocytic dysplasia

Bennett,J. M.;.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003; 21(15): 3004; author reply 3004-5.

A pediatric approach the WHO classification of myelodysplastic and myeloproliferative diseases.

Hassle H, Niemeyer C, Chessells J, Baumann I, Bennett JM, Kerndrup G, Head D.

Leukemia. 2003; .

The myelodysplastic syndromes classification and prognosis.

Komrokji R, Bennett JM.

Hematology Reports. 2003; 22: 179-185.

The FAB/MIC/WHO proposals for the classification of the chronic lymphoid leukemias.

Bennett JM

Reviews in clinical and experimental hematology. 2002 December 6 (4):330-4. Epub 1900 01 01.

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

Larson RA, Boogaerts M, Estey E, Karanes C, Stadtmauer EA, Sievers EL, Mineur P, Bennett JM, Berger MS, Eten CB, Munteanu M, Loken MR, Van Dongen JJ, Bernstein ID, Appelbaum FR,

Leukemia.. 2002 September 16 (9):1627-36. Epub 1900 01 01.

The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002).

Bennett JM, Kouides PA, Forman SJ

International journal of hematology.. 2002 August 76 Suppl 2 :228-38. Epub 1900 01 01.

Chronic myelomonocytic leukemia.

Bennett JM

Current treatment options in oncology.. 2002 June 3 (3):221-3. Epub 1900 01 01.

Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary.

Bennett JM, Brunning RD, Vardiman JW

Blood.. 2002 April 1599 (8):3074-5. Epub 1900 01 01.

Response to the letter of Dr. Karin Hartmann and Dr. Beate M. Henz.

Valent P and Bennett JM.

Leukemia Research. 2002; 26: 485-486.

WHO Classification of the Acute Myeloid Leukemias and Myelodysplastic Syndromes.

Bennett JM.

Frontiers in Haematology Oncology. 2002; 1: 1-4.

Chronic Myelomonocytic Leukemia current treatment and options

Bennett JM.

Oncology. 2002; 3: 221-223.

Myelodysplastic syndromes standardized response criteria: further definition.

Cheson BD, Bennett JM, Kantarjian H, Schiffer CA, Nimer SD, Löwenberg B, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Greenberg PL

Blood.. 2001 September 1598 (6):1985. Epub 1900 01 01.

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.

Sievers EL, Larson RA, Stadtmauer EA, Estey E, Löwenberg B, Dombret H, Karanes C, Theobald M, Bennett JM, Sherman ML, Berger MS, Eten CB, Loken MR, van Dongen JJ, Bernstein ID, Appelbaum FR,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2001 July 119 (13):3244-54. Epub 1900 01 01.

Is this "MDS" or not?

Bennett JM

Cancer genetics and cytogenetics.. 2001 July 1128 (1):50. Epub 1900 01 01.

Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.

Valent P, Sperr WR, Samorapoompichit P, Geissler K, Lechner K, Horny HP, Bennett JM

Leukemia research.. 2001 July 25 (7):595-602. Epub 1900 01 01.

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM

Leukemia research.. 2001 July 25 (7):603-25. Epub 1900 01 01.

DNA content of granulocytes, monocytes, and lymphocytes in the bone marrow smears of patients with myelodysplastic syndromes.

Widell S, Hast R, Cox C, Auer G, Bennett JM

American journal of hematology.. 2001 June 67 (2):112-8. Epub 1900 01 01.

Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity.

Paietta E, Neuberg D, Richards S, Bennett JM, Han L, Racevskis J, Dewald G, Rowe JM, Wiernik PH,

American journal of hematology.. 2001 March 66 (3):189-96. Epub 1900 01 01.

Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid.

Douer D, Estey E, Santillana S, Bennett JM, Lopez-Bernstein G, Boehm K, Williams T

Blood.. 2001 January 197 (1):73-80. Epub 1900 01 01.

Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.

Bennett JM, Young MS, Liesveld JL, Paietta E, Miller KB, Lazarus HM, Marsh RD, Friedenberg WR, Saba HT, Hayes FA, Dewald GW, Hiddemann W, Rowe JM

American journal of hematology.. 2001 January 66 (1):23-7. Epub 1900 01 01.

Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).

Wiernik PH, Leong T, Oken MM, Neiman RS, Habermann TM, Bennett JM, Schuster S, Glick JH

Leukemia & lymphoma.. 2001 January 40 (3-4):357-63. Epub 1900 01 01.

Summon up the blood: in dogged pursuit of the blood r regulators. Book review.

Bennett JM.

Leukemia Research. 2001; 25: 271.

Response: Clarifications of response criteria in myelodysplastic syndrome.

Cheson BD, Bennett JM, and Greenberg PL.

Blood. 2001; 97: 3322.

Preface.

Valent P, Bennett JM.

Leukemia Research. 2001; 25: 509-510.

Cancer and Aging: Why Niot Waltz Together?

Bennett JM.

CA Cancer J Clin. 2001; 51: 327-328.

Acute myeloid leukemia in World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues.

Brunning RD, Matutes E, Harris NL, Flandrin G, Vardiman J, Bennett JM, Head D.

IARC Press. 2001; : 75-106.

Precursor B-and T-cell neoplasms in World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues.

Brunning RD, Borowitz M, Matutes E, Head D,Flandrin G, Swerdlow SH, Bennett JM.

IARC Press. 2001; : 109-115.

Bleomycin, Lomustine, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone (BLEO-CCVPP) in Patients with Hodgkin's Disease who Relapsed after Radiotherapy Alone: a Long-Term Follow-up Study of the Eastern Cooperative Oncology Group (E3481).

Wiernik PH, Leong T, Oken MM, Neiman RS, Habermann TM, Bennett JM, Schuster S, and Glick JH.

Leukemia and Lymphoma. 2001; 40: 357-363.

Response: Clarifications of response criteria in myelodysplastic syndrome.

Chosen BD, Bennett JM, Greenberg PL.

Blood. 2001; 97.

Chronic myelomonocytic leukaemia in World Helth Organization Classification of Tumors: Pathology and genetics of Tumors of Haemotopoietic and Lymphoid Tissues.

Yardman JW, Pierr R, Bain B, Bennett JM, Imbert M, Brunning Rd, Flandrin G.

IARC Press. 2001; : 49-52.

Myelodysplastic syndromes in World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues.

Brunning Rd, Bennett JM, Flandrin G, Matutes E, Head D, Vardiman JW, Harris NL.

IARC Press. 2001; : 61-73.

Cancer vaccines and immunotherapy.

Bennett JM.

Leuk Res. 2001; 25: 1031.

Cancer and aging: why not waltz together?

Bennett JM

CA: a cancer journal for clinicians.. 2001 51 (6):327-8, 322. Epub 1900 01 01.

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, Löwenberg B, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Gore S, Greenberg PL,

Blood.. 2000 December 196 (12):3671-4. Epub 1900 01 01.

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.

Flinn IW, Kopecky KJ, Foucar MK, Head D, Bennett JM, Hutchison R, Corbett W, Cassileth P, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson B, Grever MR

Blood.. 2000 November 196 (9):2981-6. Epub 1900 01 01.

Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.

Tallman MS, Neuberg D, Bennett JM, Francois CJ, Paietta E, Wiernik PH, Dewald G, Cassileth PA, Oken MM, Rowe JM

Blood.. 2000 October 196 (7):2405-11. Epub 1900 01 01.

Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group.

Greenberg P, Anderson J, de Witte T, Estey E, Fenaux P, Gupta P, Hamblin T, Hellstrom-Lindberg E, List A, Mufti G, Neuwirtova R, Ohyashiki K, Oscier D, Sanz G, Sanz M, Willman C

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2000 October 118 (19):3447-52. Epub 1900 01 01.

Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995.

Gordon MS, Young ML, Tallman MS, Cripe LD, Bennett JM, Paietta E, Longo W, Gerad H, Mazza J, Rowe JM

Leukemia research.. 2000 October 24 (10):871-5. Epub 1900 01 01.

Peer review.

Hamblin TJ, Bennett JM

Leukemia research.. 2000 August 24 (8):639-40. Epub 1900 01 01.

Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group.

Lee S, Tallman MS, Oken MM, Cassileth PA, Bennett JM, Wiernik PH, Rowe JM

Leukemia.. 2000 August 14 (8):1345-8. Epub 1900 01 01.

Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483).

Robles C, Kim KM, Oken MM, Bennett JM, Letendre L, Wiernik PH, O'Connell MJ, Cassileth PA

Leukemia.. 2000 August 14 (8):1349-53. Epub 1900 01 01.

Large-field, external beam irradiation as a surgical adjuvant for node-positive colon carcinoma: an Eastern Cooperative Oncology Group Pilot Study (PA285).

Merrick HW, Turner SS, Dobelbower RR, Bennett JM, Haller D

American journal of clinical oncology.. 2000 August 23 (4):337-40. Epub 1900 01 01.

World Health Organization classification of the acute leukemias and myelodysplastic syndrome.

Bennett JM

International journal of hematology.. 2000 August 72 (2):131-3. Epub 1900 01 01.

Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17).

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Willman CL

Leukemia.. 2000 July 14 (7):1197-200. Epub 1900 01 01.

Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492.

Horning SJ, Williams J, Bartlett NL, Bennett JM, Hoppe RT, Neuberg D, Cassileth P

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2000 March 18 (5):972-80. Epub 1900 01 01.

Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group.

Hochster HS, Oken MM, Winter JN, Gordon LI, Raphael BG, Bennett JM, Cassileth PA

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2000 March 18 (5):987-94. Epub 1900 01 01.

Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study Group.

Thompson JA, Gilliland DG, Prchal JT, Bennett JM, Larholt K, Nelson RA, Rose EH, Dugan MH

Blood.. 2000 February 1595 (4):1175-9. Epub 1900 01 01.

Acute myelogenous leukemia and aging. Clinical interactions.

Lancet JE, Willman CL, Bennett JM

Hematology/oncology clinics of North America.. 2000 February 14 (1):251-67. Epub 1900 01 01.

Large-field, external beam irradiation as a surgical adjuvant for node-positive colon carcinoma: an Eastern Cooperative Oncology Group Pilot Study (PA285)

Merrick,H. W.; Turner,S. S.; Dobelbower,R. R.,Jr; Bennett,J. M.; Haller,D.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 2000; 23(4): 337-340.

The myelodysplastic syndromes: Morphology and risk assessment.

Bennett JM and Kouides PA.

Education Prog Book, 28th World Congress: Inter Soc of Haematology, Toronto, Canada. 2000; : 35-40.

Childhood Leukemia.

Bennett JM., C-H Pui,.

Leukemia Research. 2000; 24: 271.

Clinical Bone Marrow and Blood Stem Cell Transplantation: A Reference Textbook. Book Review.

Bennett, JM.

Leukemia Research. 2000; 24.

Letter to Editor. Reply to "Problematic WHO reclassification of myelodysplastic syndromes.

Bennett JM, Flandrin G, Matutes E, Bloomfield CD, Head D, Pierre R, Brunning RD, Imbert M, Vardiman J.

J Clin Oncol. 2000; 18(19): 3449-3451.

Assessment of the Stanford V regimen and consolidate radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1462.

Horning SJ, Williams J, Bartlett NL, Bennett JM, Hoppe RT, Neuberg D, Cassileth P.

J Clin Onco. 2000; 18(5): 972-980.

Modern Hematology Biology and clinical management.

Bennett JM.

Leuk. Res. 2000; 24: 459.

Aplastic Anemia Pathophysiology and Treatment.

Bennett JM.

Leuk. Res. 2000; 24: 459.

Expression of cyclooxygenase-2 and prostaglandins by B-1 cells and B-CLL cells.

Phipps RP, Pollock SJ, Kaur K, Kaufman J, Borrello MA, Graf BA, Nazarenko D, Roberts LJ, Morrow JD, Palis J, Ryan DJ, Bennett JM

Current topics in microbiology and immunology.. 2000 252 :293-300. Epub 1900 01 01.

A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cells.

Bennett JM, Kaye S, Berry N, Tedder RS

Journal of virological methods.. 1999 December 83 (1-2):11-20. Epub 1900 01 01.

DNA image cytometry in MDS bone marrow smears.

Widell S, Hast R, Auer G, Cox C, Bennett JM

British journal of haematology.. 1999 June 105 (4):960-5. Epub 1900 01 01.

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.

Tallman MS, Lee S, Sikic BI, Paietta E, Wiernik PH, Bennett JM, Rowe JM

Cancer.. 1999 January 1585 (2):358-67. Epub 1900 01 01.

Author responsibility (Editorial)

Bennett JM, Hamblin TJ.

Leukemia Research. 1999; 23: 97.

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Airlie House, Virginia, November l997.

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink,KH, Vardiman J, Lister TA, Bloomfield CD.

JCO. 1999; 12: 3835-3849.

Acute Leukemia: difficult, controversial automated analysis.

Bennett JM.

Leuk Res. 1999; 23: 201.

Advances in the therapy of the myelodysplastic syndromes.

Kouides PA, Bennett JM

Cancer treatment and research.. 1999 99 :335-62. Epub 1900 01 01.

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.

Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, Willman C, Hurd DD, Bennett JM, Blume KG, Head DR, Wiernik PH

The New England journal of medicine.. 1998 December 3339 (23):1649-56. Epub 1900 01 01.

Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience.

Paietta E, Racevskis J, Bennett JM, Neuberg D, Cassileth PA, Rowe JM, Wiernik PH

Leukemia.. 1998 December 12 (12):1881-5. Epub 1900 01 01.

NCCN practice guidelines for the myelodysplastic syndromes. National Comprehensive Cancer Network.

Oncology.. 1998 November 12 (11A):53-80. Epub 1900 01 01.

Under-reporting of clinical trials is a well known 'occupational hazard'.

Bennett JM, Hamblin TJ

Leukemia research.. 1998 October 22 (10):v-vii, ix. Epub 1900 01 01.

Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481).

Wiernik PH, Moore DF, Bennett JM, Vogl SE, Harris JE, Luger S, Oken MM, Glick JH

Leukemia & lymphoma.. 1998 August 30 (5-6):601-7. Epub 1900 01 01.

Phase II study of carboplatin in blast crisis of chronic myeloid leukemia: Eastern Cooperative Oncology Group Study E1992.

Dutcher JP, Lee S, Paietta E, Bennett JM, Stewart JA, Wiernik PH

Leukemia.. 1998 July 12 (7):1037-40. Epub 1900 01 01.

Case 5-1998: bone marrow blasts in chronic myelomonocytic leukemia.

Bennett JM

The New England journal of medicine.. 1998 June 25338 (26):1925-6. Epub 1900 01 01.

Meeting highlights: therapeutic strategies and supportive care in myelodysplastic syndromes: yesterday, today and tomorrow.

Bennett JM

Leukemia research.. 1998 May 22 Suppl 1 :S1-2. Epub 1900 01 01.

Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.

Greipp PR, Leong T, Bennett JM, Gaillard JP, Klein B, Stewart JA, Oken MM, Kay NE, Van Ness B, Kyle RA

Blood.. 1998 April 191 (7):2501-7. Epub 1900 01 01.

Diagnosis and Management of Anemia in Patients With the Myelodysplastic Syndrome.

Bennett JM

Cancer control : journal of the Moffitt Cancer Center.. 1998 March 5 (2 Suppl 1):41-45. Epub 1900 01 01.

Inv(16) and eosinophilia in CMMoL.

Bennett JM

Cancer genetics and cytogenetics.. 1998 February 101 (1):81. Epub 1900 01 01.

Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group.

Paietta E, Andersen J, Yunis J, Rowe JM, Cassileth PA, Tallman MS, Bennett JM, Wiernik PH

British journal of haematology.. 1998 February 100 (2):265-72. Epub 1900 01 01.

Editorial, Medical editors trial amnesty

Bennett JM, Hamblin TJ.

Leukemia Research. 1998; 22.

Medical oncology and geriatric medicine: It is time for fellowship integration.

Bennett JM, Sahasrabudhe DM, Hall WJ.

Ann of Oncology. 1998; 9(Supp 3).

Therapeutic strategies and supportive care in myelodysplastic syndromes: yesterday, today and tomorrow.

Bennett JM.

Leuk. Res. 1998; : 22.

Diagnosis and management of anemia in patients with the myelodysplastic syndrome.

Bennett JM, Kouides P.

Cancer Control. 1998; 5(S1): 44-49.

NCCN guidelines for the myelodysplastic syndromes

Greenberg P, Bishop M, Deeg J, Ester E, Erba H, Gore S, Nimer S, O'Donnell M, Stone R, Tallman M, Bennett JM.

Oncology. 1998; 12(11): 53-80.

Medical surveillance for hematological disorders among active and retired oil refinery workers.

Thai SP, Bennett JM, Salesman CN, Ryan TE, Gilstrap EL, Ross CE.

JOEM. 1998; 40: 475-480.

Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.

Bennett JM, Young ML, Andersen JW, Cassileth PA, Tallman MS, Paietta E, Wiernik PH, Rowe JM

Cancer.. 1997 December 180 (11 Suppl):2205-9. Epub 1900 01 01.

Medical oncology and geriatric medicine: is it time for fellowship integration?

Bennett JM, Sahasrabudhe DM, Hall WJ

Cancer.. 1997 October 180 (7):1351-3. Epub 1900 01 01.

Application of the International Scoring System for myelodysplasia to M.D. Anderson patients.

Estey E, Keating M, Pierce S, Beran M

Blood.. 1997 October 190 (7):2843-6. Epub 1900 01 01.

An atypical case of plasma cell leukemia.

Newman CL, Collichio FA, Bennett JM

Leukemia research.. 1997 October 21 (10):1003-6. Epub 1900 01 01.

Trilineage extramedullary myeloid cell tumor in myelodysplastic syndrome.

Hancock JC, Prchal JT, Bennett JM, Listinsky CM

Archives of pathology & laboratory medicine.. 1997 May 121 (5):520-3. Epub 1900 01 01.

International scoring system for evaluating prognosis in myelodysplastic syndromes.

Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J

Blood.. 1997 March 1589 (6):2079-88. Epub 1900 01 01.

Acute leukemia in the elderly.

Bennett JM.

Oncology Forum. 1997; 1(13).

Biologic Diagnosis of Leukemias. Temas de Hematologia

Goasguen JE and Bennett JM.

Programa Educacional e Conferencias do XVI Congresso Nacional do Colegis Brasileiro de Hematologia. 1997; : 13-29.

Advances in the Therapy of the Myelodysplastic syndromes.

Kouides PA and Bennett JM.

Hematologia. 1997; : 112-132.

Response to letter to the editor on "International prognostic scoring system and other prognostic systems for Myelodysplastic Syndromes

Greenberg P, Cox C, Bennett JM.

Blood. 1997; 90: 4233-4234.

Understanding the Myelodysplastic Syndromes.

Kouides PA, Bennett JM

The oncologist.. 1997 2 (6):389-401. Epub 1900 01 01.

Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOG.

Haferlach T, Bennett JM, Löffler H, Gassmann W, Andersen JW, Tuzuner N, Casslleth PA, Fonatsch C, Schoch C, Schlegelberger B, Becher R, Thiel E, Ludwig WD, Sauerland MC, Heinecke A, Büchner T

Leukemia & lymphoma.. 1996 October 23 (3-4):227-34. Epub 1900 01 01.

Morphologic classification of acute myeloid leukemia: concordance among Eastern Cooperative Oncology Group investigators: a comment.

Bennett JM, Cassileth PA, Paietta E, Rowe JM, Wiernik PH

Leukemia.. 1996 August 10 (8):1365. Epub 1900 01 01.

Clinical use of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy.

Lifton R, Bennett JM

Hematology/oncology clinics of North America.. 1996 August 10 (4):825-39. Epub 1900 01 01.

Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.

Nagai K, Kohno T, Chen YX, Tsushima H, Mori H, Nakamura H, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M, Bennett JM

Leukemia research.. 1996 July 20 (7):563-74. Epub 1900 01 01.

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR

Blood.. 1996 June 1587 (12):4990-7. Epub 1900 01 01.

De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.

Gahn B, Haase D, Unterhalt M, Drescher M, Schoch C, Fonatsch C, Terstappen LW, Hiddemann W, Büchner T, Bennett JM, Wörmann B

Leukemia.. 1996 June 10 (6):946-51. Epub 1900 01 01.

Prophylactic antibiotics for the prevention of early infection in multiple myeloma.

Oken MM, Pomeroy C, Weisdorf D, Bennett JM

The American journal of medicine.. 1996 June 100 (6):624-8. Epub 1900 01 01.

Morphology and classification of the myelodysplastic syndromes and their pathologic variants.

Kouides PA, Bennett JM

Seminars in hematology.. 1996 April 33 (2):95-110. Epub 1900 01 01.

t(8:21) Myelodysplasia.

Hamblin TJ, Bennett JM

British journal of haematology.. 1996 March 92 (3):766-7. Epub 1900 01 01.

Acute leukemia with t(10;11)(p11-p15;q13-q23).

Secco C, Wiernik PH, Bennett JM, Paietta E

Cancer genetics and cytogenetics.. 1996 January 86 (1):31-4. Epub 1900 01 01.

The hemopoietic colony-stimulating factors: From biology to clinical applications.

Bennett JM.

Leukemia Research. 1996; 19(9).

Hypoplastic myelodysplasia (MDS).

Tuzuner N, Cox C,. Rowe J, Waltrous D, Bennett JM.

Brit J Haematol. 1996; 94(3): 582-583.

Incidence of infections in adult patients (>55 years) with acute myeloid leukemia treated with yeast-derived GM-CSF (sargramostim): Results of a double-blind prospective study by the Eastern Cooperative Oncology Group.

Rowe JM, Rubin A, Mazza JJ, Bennett JM, Paietta E, Anderson JW, Ghalie R, Wiernick PH.

Acute Leukemias V: Experimental Approaches and Management of Refractory Diseases. 1996; : 178-184.

Appointment of Assistant Editors, Editorial

Bennett JM and Hamblin TJ.

Leukemia Research. 1996; 20(9): 703.

Biologic Diagnosis of Leukemias.

Goasguen JE, Bennett JM, Henderson ES. 6th Ed, Eds Henderson, Lister, Greaves.

Leukemia. 1996; : 8-33.

Polycythemia vera associated with metastatic carcinoid.

Sham RL, von Doenhoff L, Dipoala J, Shah A, Pande P, Bennet JM

Cancer investigation.. 1996 14 (2):120-3. Epub 1900 01 01.

Hypocellular myelodysplastic syndromes (MDS): new proposals.

Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM

British journal of haematology.. 1995 November 91 (3):612-7. Epub 1900 01 01.

A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group.

Dutcher JP, Leong T, Makary AZ, Bennett J, Frontiera M, Miller H, Wiernik PH

Leukemia.. 1995 October 9 (10):1638-42. Epub 1900 01 01.

Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.

Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH

Blood.. 1995 August 1586 (4):1540-7. Epub 1900 01 01.

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH

Blood.. 1995 July 1586 (2):457-62. Epub 1900 01 01.

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.

Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC, Rowe JM, Wiernik PH

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1995 July 13 (7):1557-63. Epub 1900 01 01.

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.

Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S

The New England journal of medicine.. 1995 June 29332 (26):1744-8. Epub 1900 01 01.

Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.

Paredes J, Kahn JO, Tong WP, Feldstein ML, Lin S, Bennett JM, Metroka CE, Ratner L, Krown SE

Journal of acquired immune deficiency syndromes and human

Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome.

Kouides PA, Bennett JM

American journal of hematology.. 1995 June 49 (2):157-62. Epub 1900 01 01.

Translocation (8;21) in acute myeloid leukemia: when to treat? That is the question!!

Bennett JM

Leukemia research.. 1995 May 19 (5):357-8. Epub 1900 01 01.

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

Grever M, Kopecky K, Foucar MK, Head D, Bennett JM, Hutchison RE, Corbett WE, Cassileth PA, Habermann T, Golomb H

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1995 April 13 (4):974-82. Epub 1900 01 01.

Secondary acute myeloid leukemia.

Bennett JM

Leukemia research.. 1995 April 19 (4):231-2. Epub 1900 01 01.

Myelodysplastic Syndromes.

Kouides PA and Bennett JM.

Clinical Oncology. 1995; .

Intensive therapy of secondary leukaemias and myelodysplastic syndromes.

Bennett JM, Fenaux P, Hiddeman W.

Trends in Onco-Hematol. 1995; 3(1): 7-9.

Guidelines on the management of patients with chronic lymphocytic leukemia who are receiving therapy with Fludara. Proc of a Conference

Bennett J, Cheson BD, Grever M, Kay N, Keating MJ, O'Brien S.

Berlex Laboratories. 1995; : 1-12.

Diagnosis and management of myelodysplastic syndromes.

Bennett JM and Kouides A. IIIIth Meeting:.

International Society of Haematology, Istanbul, Turkey. 1995; : 86-98.

Myelodysplastic syndromes: historical aspects and prognostic factors. In: Myelodysplastic Syndromes

Bennett JM, Vallespi T and Hoelzer D.

Advances in Research and Treatment. 1995; : 3-14.

Uniform publishing criteria for clinical trials

Bennett JM and Hamblin TJ.

Editorial, Leukemia Research. 1995; 19(9): 587-588.

An ECOG Phase II study of Carboplatin in blast crisis of chronic myelogenous leukemia (CML-BC) (El992).

Dutcher JP, Lee S, Paietta E, Bennett J, Stewart J, Wiernik PH.

Blood. 1995; .

The use of hematopoietic growth factors (HGF) in acute myelogenous leukemia (AML).

Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Wiernik PH.

Annals of Hematology. 1995; 70.

Recommended procedures for the classification of acute leukaemias.

Scott CS, Den Ottolander GJ, Swirsky D, Pangalis GA, Vives Corrons JL, De Pasquale A, Van Hove L, Bennett JM, Namba K, Flandrin G

Leukemia & lymphoma.. 1995 18 Suppl 1 :1-12. Epub 1900 01 01.

Hypocellular acute myeloid leukemia: the Rochester (New York) experience.

Tuzuner N, Cox C, Rowe JM, Bennett JM

Hematologic pathology. 1995 9 (3-4):195-203. Epub 1900 01 01.

B-cell acute lymphoblastic leukemia with L1 morphology and coexistence of t(1;19) and t(14;18) chromosome translocations.

Kouides PA, Phatak PD, Wang N, Bennett JM

Cancer genetics and cytogenetics.. 1994 November 78 (1):23-7. Epub 1900 01 01.

Medical bioresearch and scientific integrity.

Bennett JM, Hamblin TJ

Leukemia research.. 1994 October 18 (10):725-6. Epub 1900 01 01.

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick H, Sultan C, Cox C

British journal of haematology.. 1994 August 87 (4):746-54. Epub 1900 01 01.

Bone marrow cellularity in myeloid stem cell disorders: impact of age correction.

Tuzuner N, Cox C, Rowe JM, Bennett JM

Leukemia research.. 1994 August 18 (8):559-64. Epub 1900 01 01.

Reference standards for bone marrow cellularity.

Tuzuner N, Bennett JM

Leukemia research.. 1994 August 18 (8):645-7. Epub 1900 01 01.

The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.

Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH

Leukemia.. 1994 July 8 (7):1108-12. Epub 1900 01 01.

Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.

Paietta E, Andersen J, Racevskis J, Gallagher R, Bennett J, Yunis J, Cassileth P, Wiernik PH

Leukemia.. 1994 June 8 (6):968-73. Epub 1900 01 01.

The study and treatment of the myelodysplastic patient.

Sanz MA, Bennett JM, Vallespí T, Hoelzer D

Revista de investigacio?n cli?nica; organo del Hospital de Enfermedades de la Nutricio?n.. 1994 April Suppl :61-73. Epub 1900 01 01.

Myelodysplastic syndrome and acute myeloid leukemia secondary to mitolactol treatment in patients with breast cancer.

Bennett JM, Troxel AB, Gelman R, Falkson G, Coccia-Portugal MD, Dreicer R, Tormey DC, Rushing D

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1994 April 12 (4):874-5. Epub 1900 01 01.

Use of cell surface antigen phenotype in guiding therapeutic decisions in chronic myelomonocytic leukemia.

Woodlock TJ, Seshi B, Sham RL, Cyran EM, Bennett JM

Leukemia research.. 1994 March 18 (3):173-81. Epub 1900 01 01.

Editorial: Editorial Policy.

Bennett JM and Hamblin TJ.

Leuk Res. 1994; 18(3): 147.

Age and Hodgkin's disease: the impact of competing risks and possibly salvage therapy on long term survival: an E.C.O.G. study.

Bennett JM, Andersen JW, Begg CB, Glick JH

Leukemia research.. 1993 October 17 (10):825-32. Epub 1900 01 01.

Recommended procedures for the classification of acute leukaemias. International Council for Standardization in Haematology (ICSH).

Scott CS, Den Ottolander GJ, Swirsky D, Pangalis GA, Vives Corrons JL, de Pasquale A, van Hove L, Bennett JM, Namba K, Flandrin G

Leukemia & lymphoma.. 1993 September 11 (1-2):37-50. Epub 1900 01 01.

Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup study.

Goldberg J, Gryn J, Raza A, Bennett J, Browman G, Bryant J, Grunwald H, Larson R, Vogler R, Preisler H

American journal of hematology.. 1993 August 43 (4):286-90. Epub 1900 01 01.

Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.

Paietta E, Racevskis J, Bennett JM, Wiernik PH

British journal of haematology.. 1993 July 84 (3):416-22. Epub 1900 01 01.

Myelodysplastic syndromes: a forum for debate and discussion.

Bennett JM

Leukemia research.. 1993 June 17 (6):475. Epub 1900 01 01.

Three cases of familial hairy cell leukemia.

Gramatovici M, Bennett JM, Hiscock JG, Grewal KS

American journal of hematology.. 1993 April 42 (4):337-9. Epub 1900 01 01.

Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia.

Raza A, Preisler HD, Li YQ, Larson RA, Goldberg J, Browman G, Bennett J, Grunwald H, Vogler R, Kukla C

American journal of hematology.. 1993 April 42 (4):359-66. Epub 1900 01 01.

Autologous bone marrow transplant in acute myeloid leukemia in first remission.

Cassileth PA, Andersen J, Lazarus HM, Colvin OM, Bennett JM, Stadtmauer EA, Kaizer H, Weiner RS, Edelstein M, Oken MM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1993 February 11 (2):314-9. Epub 1900 01 01.

Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia.

Raza A, Preisler H, Lampkin B, Lykins J, Kukla C, Gartside P, Sheikh Y, Yousuf N, White M, Barcos M

American journal of hematology.. 1993 February 42 (2):147-57. Epub 1900 01 01.

Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.

Cummings FJ, Gray R, Tormey DC, Davis TE, Volk H, Harris J, Falkson G, Bennett JM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1993 January 11 (1):29-35. Epub 1900 01 01.

Obituary: A personal tribute to Professor Claude Sultan.

Bennett JM.

Hematol Pathology. 1993; 7(1): 57.

Differential effects of Atomic Bomb irradiation in inducing major leukemia types: Analyses of open-city cases including the life span study cohort based upon updated diagnostic systems and the dosimetry system l986 (DS86).

Tomonaga M, Matsuo T, Carter RL, Bennett JM, Kuriyama K, Imanaka F, Kusumi S, Mabuchi K, Kuramoto A, Kamada N, Ichimaru M, Pisciotta AV, Finch SC.

Radiation Effects Research Fdn, Technical Report Series. 1993; : 1-38.

Acute myeloid leukemia M4 with inv(l6) (pl3q22) exhibits a specific immunophenotype with CD2 expression.

Paietta E, Wiernik PH, Andersen J, Bennett J, Yunis J.

Blood: Letter to the Editor. 1993; 82(8): 2595.

Autologous bone marrow transplantation in hematologic neoplasms.

Bennett JM.

Advances in Leukemia and Lymphoma. 1993; 4(1): 3-11.

Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.

Raza A, Gezer S, Anderson J, Lykins J, Bennett J, Browman G, Goldberg J, Larson R, Vogler R, Preisler HD

Experimental hematology.. 1992 November 20 (10):1194-200. Epub 1900 01 01.

Detection of relapse in acute leukemia: should we discontinue routine bone marrow surveillance?

Bennett JM

Leukemia.. 1992 November 6 (11):1099-100. Epub 1900 01 01.

Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.

Rowe JM, Andersen JW, Cassileth PA, Oken MM, Bennett JM, Wiernik PH

Leukemia.. 1992 November 6 Suppl 4 :75-7. Epub 1900 01 01.

c-myc and c-myb expression in acute myelogenous leukemia.

Gopal V, Hulette B, Li YQ, Kuvelkar R, Raza A, Larson R, Goldberg J, Tricot G, Bennett J, Preisler H

Leukemia research.. 1992 October 16 (10):1003-11. Epub 1900 01 01.

Phase II clinical trial of carboplatin in relapsed and refractory leukemia.

Vogler WR, Harrington DP, Winton EF, Lazarus HM, Bennett JM, Cassileth PA, Oken MM

Leukemia.. 1992 October 6 (10):1072-5. Epub 1900 01 01.

The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.

Larson RA, Day RS, Azarnia N, Bennett JM, Browman G, Goldberg J, Gottlieb A, Grunwald H, Miller K, Raza A

British journal of haematology.. 1992 October 82 (2):337-46. Epub 1900 01 01.

The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study.

Miller KB, Kim K, Morrison FS, Winter JN, Bennett JM, Neiman RS, Head DR, Cassileth PA, O'Connell MJ, Kyungmann K

Annals of hematology.. 1992 October 65 (4):162-8. Epub 1900 01 01.

Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.

Dutcher JP, Eudey L, Wiernik PH, Paietta E, Bennett JM, Arlin Z, Kellermeyer R, Rowe J, O'Connell M, Oken M

Leukemia.. 1992 August 6 (8):770-5. Epub 1900 01 01.

Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).

Seshi B, Kashyap A, Bennett JM

British journal of haematology.. 1992 July 81 (3):374-7. Epub 1900 01 01.

Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival.

Goasguen JE, Matsuo T, Cox C, Bennett JM

Leukemia.. 1992 June 6 (6):520-5. Epub 1900 01 01.

Morphology and classification of myelodysplastic syndromes.

Kouides PA, Bennett JM

Hematology/oncology clinics of North America.. 1992 June 6 (3):485-99. Epub 1900 01 01.

Translocation (2;9)(p12;p23) in a case of acute leukemia with t(4;11)(q21;q23). Lack of rearrangement of the kappa and interferon gene loci.

Paietta E, Van Ness B, Le Beau MM, Bennett J, Cassileth P, Wiernik PH

Cancer genetics and cytogenetics.. 1992 May 60 (1):82-5. Epub 1900 01 01.

Varying intensity of postremission therapy in acute myeloid leukemia.

Cassileth PA, Lynch E, Hines JD, Oken MM, Mazza JJ, Bennett JM, McGlave PB, Edelstein M, Harrington DP, O'Connell MJ

Blood.. 1992 April 1579 (8):1924-30. Epub 1900 01 01.

Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.

Habermann TM, Andersen JW, Cassileth PA, Bennett JM, Oken MM

British journal of haematology.. 1992 April 80 (4):466-71. Epub 1900 01 01.

High expression of transforming growth factor-beta long cell cycle times and a unique clustering of S-phase cells in patients with acute promyelocytic leukemia.

Raza A, Yousuf N, Abbas A, Umerani A, Mehdi A, Bokhari SA, Sheikh Y, Qadir K, Freeman J, Masterson M

Blood.. 1992 February 1579 (4):1037-48. Epub 1900 01 01.

Classification and morphologic features of the myelodysplastic syndromes.

Goasguen JE, Bennett JM

Seminars in oncology.. 1992 February 19 (1):4-13. Epub 1900 01 01.

Clinical trials in adults with relapsed and refractory acute myelogenous leukemia: The ECOG and the University of Rochester Experience.

Rowe JM, Oken MM, Cassileth PA, Andersen W, Bennett JM, Wiernik PH.

Haematol & Blood Transfusion. 1992; 34: 392-395.

Classification of acute leukemias

Franzman C, Bennett JM.

Contemporary Oncology. 1992; 2(5): 46-54.

The role of growth factors in the treatment of the myelodysplastic syndrome.

Bennett JM.

Anemia Reviews. 1992; 1-4.

Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.

Paietta E, VanNess B, Bennett J, Racevskis J, Gucalp R, Cassileth P, Wiernik PH.

Brit J Haematol. 1992; 82: 324-331.

The acute myeloid leukemias: morphology and cytochemistry.

Goasguen J and Bennett JM.

Hematology:Clinical and Laboratory Practice. 1992; 2: 1195-1216.

Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.

Cassileth PA, Andersen JW, Bennett JM, Harrington DP, Hines JD, Lazarus HM, Mazza JJ, McGlave PP, O'Connell MJ, Paietta E

Leukemia.. 1992 6 Suppl 2 :116-9. Epub 1900 01 01.

Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.

Cassileth PA, Andersen JW, Bennett JM, Hoagland HC, Mazza JJ, O'Connell MC, Paietta E, Wiernik P

Leukemia.. 1992 6 Suppl 2 :178-81. Epub 1900 01 01.

Burkitt cell leukemia with myelodysplasia as a presentation of HIV infection.

Sham RL, Bennett JM

Hematologic pathology. 1992 6 (2):95-8. Epub 1900 01 01.

Malignant melanoma: primary presentation in bone marrow and lymph node.

Basile M, Moskowitz B, Harris J, Blumberg N, Bennett JM

Medical and pediatric oncology.. 1992 20 (1):75-7. Epub 1900 01 01.

Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study.

Yung WK, Prados M, Levin VA, Fetell MR, Bennett J, Mahaley MS, Salcman M, Etcubanas E

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1991 November 9 (11):1945-9. Epub 1900 01 01.

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO).

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

British journal of haematology.. 1991 July 78 (3):325-9. Epub 1900 01 01.

Medical surveillance for leukemia at a petrochemical manufacturing complex: four-year summary.

Cowles SR, Bennett JM, Ross CE

Journal of occupational medicine. : official publication of the Industrial Medical Association.. 1991 July 33 (7):808-12. Epub 1900 01 01.

Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.

Raphael B, Andersen JW, Silber R, Oken M, Moore D, Bennett J, Bonner H, Hahn R, Knospe WH, Mazza J

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1991 May 9 (5):770-6. Epub 1900 01 01.

13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the Eastern Cooperative Oncology Group.

Kramer ZB, Boros L, Wiernik PH, Andersen J, Bennett JM, Cassileth P, Oken M

Cancer.. 1991 March 1567 (6):1484-6. Epub 1900 01 01.

High-dose dexamethasone for refractory or relapsing multiple myeloma.

Friedenberg WR, Kyle RA, Knospe WH, Bennett JM, Tsiatis AA, Oken MM

American journal of hematology.. 1991 March 36 (3):171-5. Epub 1900 01 01.

Pentostatin induces durable remissions in hairy cell leukemia.

Cassileth PA, Cheuvart B, Spiers AS, Harrington DP, Cummings FJ, Neiman RS, Bennett JM, O'Connell MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1991 February 9 (2):243-6. Epub 1900 01 01.

Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukaemia.

Raza A, Preisler H, Lampkin B, Yousuf N, Tucker C, Peters N, White M, Kukla C, Gartside P, Siegrist C, Bismayer J, Barcos M, Bennett J, Browman G, Goldberg J, Grunwald H, Larson R, Vardiman J and Vogler R.

Brit J Haematol. 1991; 79: 33-39.

Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome.

Goasguen JE, Bennett JM, Cox C, Hambley H, Mufti G, Flandrin G

Leukemia research.. 1991 15 (12):1159-65. Epub 1900 01 01.

Unexpected immunoglobulin light chain gene rearrangements in myeloid antigen positive acute lymphoid leukemia.

Paietta E, Van Ness B, Bennett JM, Pellone C, Billadeau D, Cassileth PA, Wiernik PH

Leukemia research.. 1991 15 (2-3):149-55. Epub 1900 01 01.

Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. A Leukemia Intergroup Study.

Khan SP, Raza A, Barcos M, Yousuf N, Saikia T, Masterson M, Bennett J, Browman G, Goldberg J, Grunwald H

Leukemia research.. 1991 15 (1):51-7. Epub 1900 01 01.

Treatment patterns in low-grade non-Hodgkin's lymphomas: a single institution study.

Liesveld JL, Raubertas RF, Bennett JM

Medical and pediatric oncology.. 1991 19 (1):1-7. Epub 1900 01 01.

Long term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group (ECOG) experience.

Bennett JM, Andersen JW, Cassileth PA

Leukemia research.. 1991 15 (4):223-7. Epub 1900 01 01.

Classifications of acute myeloid leukemia.

Goasguen JE, Bennett JM

Clinics in laboratory medicine.. 1990 December 10 (4):661-81. Epub 1900 01 01.

Blastic phase of chronic myeloid leukemia (blCML): a proposal for standardization of diagnostic and response criteria.

Arlin ZA, Silver RT, Bennett JM

Leukemia.. 1990 November 4 (11):755-7. Epub 1900 01 01.

Chronic myelomonocytic leukemia.

Storniolo AM, Moloney WC, Rosenthal DS, Cox C, Bennett JM

Leukemia.. 1990 November 4 (11):766-70. Epub 1900 01 01.

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1990 May 8 (5):813-9. Epub 1900 01 01.

The use of 'CHOP' in the treatment of CLL.

Bennett JM

British journal of haematology.. 1990 April 74 (4):546. Epub 1900 01 01.

A Conference on the Morphologic, Immunologic, and Cytogenetic Classification of the Chronic (mature) B- and T-Lymphoid Leukemias: (MIC IV).

Bennett J, Juliusson G, Mecucci C.

Hematologic Pathol. 1990; 4(3): 161-162.

Meeting Report: Morphologic, Immunologic, and Cytogenetic Classification of the Chronic (mature) B and T Lymphoid Leukemias: Fourth Meeting of the MIC Cooperative Study Group.

Bennett JM, Juliusson G, Mecucci C.

Cancer Research. 1990; 50: 2212.

Mitoxantrone and Etoposide in patients with relapsed and refractory acute non lymphocytic leukemia.

Rowe JM, Mazza JJ, Hines, JD, Cassileth PA, Oken MM, Bennett JM, Andersen J.

Haematology and Blood Transfusion 33: Acute Leukemias II. 1990; : 325-329.

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

Sato H, Preisler H, Day R, Raza A, Larson R, Browman G, Goldberg J, Vogler R, Grunwald H, Gottlieb A, Bennett J, Gottesman M, and Pastan I.

Brit. J Haematol. 1990; 75: 340-345.

Does this man have a preleukemia syndrome?

Bennett JM.

Cancer Consultation in Primary Care & Cancer. 1990; : 8.

Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: A Leukemia Intergroup Study.

Raza A, Preisler HD, Day R, Yasin Y, White M, Lykins J, Kukla C, Bennett JM, Browman G, Goldberg J, Grunwald H, Larson R, Vardiman J, and Vogler R.

Blood. 1990; 76(11): 2190-2197.

Comparison of Postremission Therapies in Adult Acute Myeloid Leukemia: Prelminary Analysis of an ECOG Study.

Cassileth PA, Harrington DP, Hines JD, Oken MM, Mazz JJ, McGlave P, Bennett JM, Lynch E, OConnell MJ.

Haematology and Blood Transfusion, Acute Leukemias II. 1990; 33: 267-270.

Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia.

Rowe JM, Mazza JJ, Hines JD, Cassileth PA, Oken MM, Bennett JM, Andersen J

Haematology and blood transfusion.. 1990 33 :326-9. Epub 1900 01 01.

Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study.

Head DR, Kopecky K, Bennett JM, Grenier K, Morrison FS, Miller KB, Grever MR

Cancer.. 1989 December 164 (11):2199-2202. Epub 1900 01 01.

Treatment of refractory acute leukaemia with aclacinomycin A.

Rowe JM, Chang AY, Bennett JM

Bone marrow transplantation.. 1989 December 4 Suppl 3 :47-8. Epub 1900 01 01.

Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer.

Falkson G, Gelman RS, Dreicer R, Tormey DC, Alberts AS, Coccia-Portugal MA, Rushing D, Bennett JM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1989 September 7 (9):1252-9. Epub 1900 01 01.

A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma.

Chang AY, Bennett JM, Pandya KJ, Asbury R, McCune C

American journal of clinical oncology.. 1989 August 12 (4):358-60. Epub 1900 01 01.

Attenuated high-dose cytosine arabinoside in the treatment of the elderly patient with acute nonlymphocytic leukemia. An Eastern Cooperative Oncology Group Pilot Study.

Kahn SB, Ebrahim K, Cassileth P, Bennett JM, Knospe WH, O'Connell MJ

American journal of clinical oncology.. 1989 June 12 (3):201-4. Epub 1900 01 01.

Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

Journal of clinical pathology.. 1989 June 42 (6):567-84. Epub 1900 01 01.

Chronic lymphocytic leukemia: recommendations.

Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Oken MM, Schiffer CA, Keating MJ, Boldt DH, Kempin SJ

Annals of internal medicine.. 1989 April 15110 (8):664-5. Epub 1900 01 01.

A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma

Chang,A. Y.; Bennett,J. M.; Pandya,K. J.; Asbury,R.; McCune,C.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1989; 12(4): 358-360.

Attenuated high-dose cytosine arabinoside in the treatment of the elderly patient with acute nonlymphocytic leukemia. An Eastern Cooperative Oncology Group Pilot Study

Kahn,S. B.; Ebrahim,K.; Cassileth,P.; Bennett,J. M.; Knospe,W. H.; O'Connell,M. J.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1989; 12(3): 201-204.

Chronic Lymphocytic Leukemia: Recommendations.

Cheson BD, Bennett JM, Rai KR.

Annals Int Med. 1989; 110(8): 664.

Prognostic significance of myeloperoxidase positivity of blast cells in acute myeloblastic leukemia without maturation (FAB: M1): an ECOG study.

Matsuo T, Cox C, Bennett JM

Hematologic pathology. 1989 3 (4):153-8. Epub 1900 01 01.

Refractory acute lymphocytic leukemia: response to aclacinomycin A and VP-16-213.

Rowe JM, Chang AY, Bennett JM

Hematological oncology.. 1989 7 (6):405-10. Epub 1900 01 01.

Continuous infusion homoharringtonine (NSC 141633) in refractory acute nonlymphocytic leukemia. An ECOG pilot study.

Stewart JA, Cassileth PA, Bennett JM, O'Connell MJ

American journal of clinical oncology.. 1988 December 11 (6):627-9. Epub 1900 01 01.

Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin.

Qazi R, Chang AY, Borch RF, Montine T, Dedon P, Loughner J, Bennett JM

Journal of the National Cancer Institute.. 1988 November 1680 (18):1486-8. Epub 1900 01 01.

Nonspecific esterase of acute promyelocytic leukemia (M3).

Matsuo T, Jain NC, Bennett JM

American journal of hematology.. 1988 November 29 (3):148-51. Epub 1900 01 01.

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.

Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Boldt DH, Kempin SJ

American journal of hematology.. 1988 November 29 (3):152-63. Epub 1900 01 01.

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.

Bennett JM, Muss HB, Doroshow JH, Wolff S, Krementz ET, Cartwright K, Dukart G, Reisman A, Schoch I

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1988 October 6 (10):1611-20. Epub 1900 01 01.

Acute leukemia of megakaryocyte lineage (M7).

Matsuo T, Bennett JM

Cancer genetics and cytogenetics.. 1988 August 34 (1):1-3. Epub 1900 01 01.

Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia.

Matsuo T, Tomonaga M, Bennett JM, Kuriyama K, Imanaka F, Kuramoto A, Kamada N, Ichimaru M, Finch SC, Pisciotta AV

Japanese journal of clinical oncology.. 1988 June 18 (2):91-6. Epub 1900 01 01.

Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Report of the workshop held in Scottsdale, Arizona, USA, on February 23-25, 1987. Third MIC Cooperative Study Group.

Cancer genetics and cytogenetics.. 1988 May 32 (1):1-10. Epub 1900 01 01.

Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.

Rowe JM, Chang AY, Bennett JM

Blood.. 1988 April 71 (4):992-6. Epub 1900 01 01.

Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Second MIC Cooperative Study Group.

British journal of haematology.. 1988 April 68 (4):487-94. Epub 1900 01 01.

Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.

Cassileth PA, Harrington DP, Hines JD, Oken MM, Mazza JJ, McGlave P, Bennett JM, O'Connell MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1988 April 6 (4):583-7. Epub 1900 01 01.

High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia.

Cassileth PA, Sylvester LS, Bennett JM, Begg CB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1988 March 6 (3):495-8. Epub 1900 01 01.

Congenital left ventricular aneurysm presenting as an inferior myocardial infarction.

Carim Y, Carim S, Bennett JM

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.. 1988 February 673 (3):192. Epub 1900 01 01.

Continuous infusion homoharringtonine (NSC 141633) in refractory acute nonlymphocytic leukemia. An ECOG pilot study

Stewart,J. A.; Cassileth,P. A.; Bennett,J. M.; O'Connell,M. J.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1988; 11(6): 627-629.

Reclassification of Leukemia among A-Bomb Survivors in Nagasaki using French-American-British (FAB) Classification for Acute Leukemia

Matsuo T, Tomonaga M, Bennett JM, Kuriyama K, Imanaka F, Kuramoto A, Kamada N, Ichimaru M, Finch SC, Pisciotta AV and Ishimaru T.

Japanese. J Clin Onc. 1988; 13: 91-96.

Letter to the Editor

Bennett JM.

New Eng J Medicine. 1988; .

Morphologic Immunologic and Cytogenetic (MIC) working Classification of the Acute Myeloid Leukaemias.

Bennett JM, Berger R, Catovsky D, Flandrin G, Foon KA, Gralnick HG, Griffin JD, Gagemeijer A, Mecucci C, Monowada J, Mitelman F, Preud'homme, J-L, Sandberg AA, Van den Berghe H.

Brit J Haematol. 1988; 68: 487-494.

The prognosis and therapy of chronic lymphocytic leukemia under age 50 years.

Bennett JM, Raphael B, Oken MM, Rubin P, Silber R

Nouvelle revue française d'hématologie. 1988 30 (5-6):411-2. Epub 1900 01 01.

Effectiveness of attenuated chemotherapy in myelodysplastic syndromes: a preliminary report.

Owens MR, Bennett JM

Medical and pediatric oncology.. 1988 16 (2):107-10. Epub 1900 01 01.

Prolonged survival after high-dose cytosine arabinoside and amsacrine induction in patients with previously untreated de novo acute nonlymphocytic leukemia.

Hines JD, Mazza JJ, Oken MM, Adelstein DJ, Keller A, Bennett JM, O'Connell MJ

Seminars in oncology.. 1987 June 14 (2 Suppl 1):37-9. Epub 1900 01 01.

Evaluation of CCNU and misonidazole in the treatment of advanced colorectal cancer.

Anagnost J, Bennett JM, Sutherland RM, Boros L, Siemann DW, Mulcahy RT

American journal of clinical oncology.. 1987 June 10 (3):213-5. Epub 1900 01 01.

Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).

Spiers AS, Moore D, Cassileth PA, Harrington DP, Cummings FJ, Neiman RS, Bennett JM, O'Connell MJ

The New England journal of medicine.. 1987 April 2316 (14):825-30. Epub 1900 01 01.

Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.

Cassileth PA, Begg CB, Silber R, Spiers A, Burkart PT, Scharfman W, Knospe WH, Bennett JM, Mazza JJ, Oken MM

Cancer treatment reports.. 1987 February 71 (2):137-40. Epub 1900 01 01.

5-Fluorouracil and high-dose folic acid treatment for metastatic colon cancer.

Asbury RF, Boros L, Brower M, Woll J, Chang A, Bennett J

American journal of clinical oncology.. 1987 February 10 (1):47-9. Epub 1900 01 01.

High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.

Preisler HD, Raza A, Barcos M, Azarnia N, Larson R, Walker I, Browman M, Grunwald H, D'Arrigo P, Doeblin T

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1987 January 5 (1):75-82. Epub 1900 01 01.

Evaluation of CCNU and misonidazole in the treatment of advanced colorectal cancer

Anagnost,J.; Bennett,J. M.; Sutherland,R. M.; Boros,L.; Siemann,D. W.; Mulcahy,R. T.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1987; 10(3): 213-215.

Acute Myeloid Leukemia and Other Myelopathic Disorders Following Treatment with Alkylating Agents.

Bennett JM, Moloney WC, Greene MH and Boice JD.

Hematologic Path. 1987; 1(2): 99-104.

Auer rods in the acute myeloid leukemias: frequency and methods of demonstration.

Jain NC, Cox C, Bennett JM

Hematological oncology.. 1987 5 (3):197-202. Epub 1900 01 01.

Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agents.

Bennett JM, Moloney WC, Greene MH, Boice JD

Hematologic pathology. 1987 1 (2):99-104. Epub 1900 01 01.

Classification of the myelodysplastic syndromes.

Bennett JM

Clinics in haematology. 1986 November 15 (4):909-23. Epub 1900 01 01.

Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Report of the workshop held in Leuven, Belgium, April 22-23, 1985. First MIC Cooperative Study Group.

Cancer genetics and cytogenetics.. 1986 November 23 (3):189-97. Epub 1900 01 01.

The morphologic classification of acute lymphoblastic leukemia in childhood. Observations on concordance using a simple scoring system.

Childs CC, Stass SA, Bennett JM

American journal of clinical pathology.. 1986 October 86 (4):503-6. Epub 1900 01 01.

High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.

Preisler HD, Raza A, Barcos M, Azarnia N, Larson R, Browman G, Walker I, Grunwald H, D'Arrigo P, Stein A

American journal of hematology.. 1986 October 23 (2):131-4. Epub 1900 01 01.

The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.

Bennett JM, Cain KC, Glick JH, Johnson GJ, Ezdinli E, O'Connell MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1986 October 4 (10):1462-9. Epub 1900 01 01.

Melphalan may be a more potent leukemogen than cyclophosphamide.

Greene MH, Harris EL, Gershenson DM, Malkasian GD, Melton LJ, Dembo AJ, Bennett JM, Moloney WC, Boice JD

Annals of internal medicine.. 1986 September 105 (3):360-7. Epub 1900 01 01.

Hodgkin's disease. IIB or not to be--using irradiation alone or in combination with chemotherapy? That is the question!

Rubin P, Constine L, Bennett JM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1986 April 4 (4):455-7. Epub 1900 01 01.

Comparison of allogeneic bone marrow transplantation and chemotherapy in adult acute nonlymphocytic leukemia. An Eastern Cooperative Oncology Group Study

Cassileth,P. A.; Bennett,J. M.; Hurwitz,S.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1986; 9(1): 35-39.

Prolymphocytic Leukemia: Histologic Findings in Atypical Cases.

Owens MR, Strauchen JA, Rowe JM and Bennett JM.

Hematological Oncology. 1986; 9(10): 35-39.

The Chronic Leukemias.

Bennett JM.

Primary Care and Cancer. 1986; : 23-31.

Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia.

Preisler HD, Raza A, Larson R, Browman G, Goldberg J, Grunwald H, Vogler R, Bennett J, Gottlieb A, D'Arrigo P

Cancer chemotherapy and pharmacology.. 1986 18 (3):257-60. Epub 1900 01 01.

Effectiveness of acute nonlymphocytic leukemia induction chemotherapy in acute lymphocytic leukemia.

Cassileth PA, Bennett JM

Cancer treatment reports.. 1985 December 69 (12):1439-40. Epub 1900 01 01.

Leukemia in Rochester (NY). A 17-year experience with an analysis of the role of cooperative group (ECOG) participation.

Boros L, Chuang C, Butler FO, Bennett JM

Cancer.. 1985 November 156 (9):2161-9. Epub 1900 01 01.

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

Annals of internal medicine.. 1985 October 103 (4):620-5. Epub 1900 01 01.

Chemotherapy for metastatic Merkel cell carcinoma.

George TK, di Sant'agnese PA, Bennett JM

Cancer.. 1985 September 156 (5):1034-8. Epub 1900 01 01.

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

Annals of internal medicine.. 1985 September 103 (3):460-2. Epub 1900 01 01.

High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group.

Hines JD, Mazza JJ, Oken MM, Bennett JM, Adelstein DJ, Keller A, O'Connell MJ

Seminars in oncology.. 1985 June 12 (2 Suppl 3):117-9. Epub 1900 01 01.

Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.

Taylor SG, Kalish LA, Olson JE, Cummings F, Bennett JM, Falkson G, Tormey DC, Carbone PP

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1985 February 3 (2):144-54. Epub 1900 01 01.

Endobronchial metastases from carcinoma of the breast.

Ettensohn DB, Bennett JM and Hyde RW.

Med & Ped Oncol. 1985; 13(1): 9-13.

Recommended Methods for Cytological Procedures in Haematology.

Shibata A, Bennett JM, Castoldi GL, Catovsky D, Flandrin G, Jaffe ES, Katayama I, Nanba K, Schmalzl F and Yam LT.

Clin Lab Haemat. 1985; 7: 55-74.

Modifications in the Classification of Primary Myelodysplastic Syndromes: The Addition of a Scoring System.

Varela BL, Chuang C, Woll JE, and Bennett JM.

Hematol Oncology. 1985; 3(1): 54-63.

Treatment of Patients with Acute Nonlymphocytic Leukemia in Relapse.

Goldberg J, Grunwald H, Vogler WR, Winton E, Browman G, Walker I, Benger A, Miller KB, Rai K, Gottlieb AJ, Brennan JK, Bennett JM, Chervenick P, Joyce R, Azarnai, Priore RL and Preisler HD.

Am J of Hematol. 1985; 19: 167-176.

Modifications in the classification of primary myelodysplastic syndromes: the addition of a scoring system.

Varela BL, Chuang C, Woll JE, Bennett JM

Hematological oncology.. 1985 3 (1):55-63. Epub 1900 01 01.

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.

Bennett JM, Byrne P, Desai A, White C, DeConti R, Vogel C, Krementz E, Muggia F, Doroshow J, Plotkin D

Investigational new drugs.. 1985 3 (2):179-85. Epub 1900 01 01.

Endobronchial metastases from carcinoma of the breast.

Ettensohn DB, Bennett JM, Hyde RW

Medical and pediatric oncology.. 1985 13 (1):9-13. Epub 1900 01 01.

Recommended methods for cytological procedures in haematology. International Committee for Standardization in Haematology (ICSH).

Shibata A, Bennett JM, Castoldi GL, Catovsky D, Flandrin G, Jaffe ES, Katayama I, Nanba K, Schmalzl F, Yam LT

Clinical and laboratory haematology.. 1985 7 (1):55-74. Epub 1900 01 01.

Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.

Levin M, Pandya KJ, Khandekar JD, Horton J, Glick JH, Bennett JM, Muggia FM, Falkson G

Cancer treatment reports.. 1984 December 68 (12):1511-2. Epub 1900 01 01.

Phase II trial of cisplatin in advanced gastric cancer.

Vogl SE, Camacho FJ, Engstrom PF, Bennett JM

Cancer treatment reports.. 1984 December 68 (12):1497-8. Epub 1900 01 01.

A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study.

Bennett JM, Lymann GH, Cassileth PA, Glick JH, Oken MM

American journal of clinical oncology.. 1984 October 7 (5):471-3. Epub 1900 01 01.

Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.

Kahn SB, Begg CB, Mazza JJ, Bennett JM, Bonner H, Glick JH

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1984 August 2 (8):865-70. Epub 1900 01 01.

High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study.

Cassileth PA, Lyman GH, Bennett JM, Glick JH, Oken MM

American journal of clinical oncology.. 1984 August 7 (4):361-3. Epub 1900 01 01.

A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia.

Begg CB, McGlave PB, Bennett JM, Cassileth PA, Oken MM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1984 May 2 (5):369-78. Epub 1900 01 01.

A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia.

Cassileth PA, Begg CB, Bennett JM, Bozdech M, Kahn SB, Weiler C, Glick JH

Blood.. 1984 April 63 (4):843-7. Epub 1900 01 01.

Myelodysplastic syndromes: is another classification necessary?

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

British journal of haematology.. 1984 March 56 (3):515-7. Epub 1900 01 01.

Proceedings of the international round table conference: FAB classification of acute leukemias correlating with response to chemotherapy.

Amaki I, Hattori K, Bennett JM, Yoshida T, Tomonaga M, Ogawa T, Catovsky D, Shimoyama M, Ohshima T, Fujimoto T

Nippon Ketsueki Gakkai zasshi : journal of Japan Haematological

Oncogenes and acute leukemias.

Goh KO, Qazi R, Owens M, Herrmann M, Bennett JM

Blood.. 1984 January 63 (1):242. Epub 1900 01 01.

A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study

Bennett,J. M.; Lymann,G. H.; Cassileth,P. A.; Glick,J. H.; Oken,M. M.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1984; 7(5): 471-473.

High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study

Cassileth,P. A.; Lyman,G. H.; Bennett,J. M.; Glick,J. H.; Oken,M. M.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1984; 7(4): 361-363.

Prediction of Response of Acute Nonlymphocytic Leukaemia to Therapy with 'High Dose' Cytosine Arabinoside.

Preisler HD, Epstein J, Barcos M, Priore R, Raza A, Browman GP, Vogler R, Winton E, Grunwald H, Rai K, Brennan J, Bennett JM, Goldberg J, Gottlieb A, Chervenick P, Joyce R, Miller K, Larson R, Arrigo PD, Doeblin T, Stein M, Bloom M, Steele R and Lee, H.

Brit J Haematol. 1984; 58(1): 19-32.

Treatment of Myeloid Blastic Crisis of Chronic Myelogenous Leukemia.

Preisler HD, Raza A, Higby D, Kirshner J, Woll J, Bennett J, Winton L, Weiner R, Richman C, Golomb H and Golberg J.

Canc Treat Rep. 1984; 68(11): 1351-1355.

Proposals for the Classification of Acute Leukemia.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR and Sultan C.

Citation Classic from Current Contents. 1984; 27(47): 20.

Prolymphocytic leukemia: histologic findings in atypical cases.

Owens MR, Strauchen JA, Rowe JM, Bennett JM

Hematological oncology.. 1984 2 (3):249-57. Epub 1900 01 01.

A new concept in the surgical treatment of gastroesophageal reflux.

Bennett JM

Annals of surgery.. 1983 November 198 (5):670. Epub 1900 01 01.

Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphoma.

Johnson GJ, Costello WG, Oken MM, Sponzo RW, Barnes JM, Ezdinli EZ, Bennett JM, Silverstein MN, Glick JH, Berard CW

Cancer.. 1983 October 152 (7):1133-41. Epub 1900 01 01.

Etoposide in small cell lung cancer resistant to prior chemotherapy.

Asbury RF, Rubins J, Bennett JM

Cancer treatment reports.. 1983 October 67 (10):951-2. Epub 1900 01 01.

Adriamycin and Cytoxan in the treatment of inoperable lung cancer.

Hoeltgen TM, MacIntyre JM, Perlia CP, Lagakos SW, Stolbach LL, Bennett JM

Cancer.. 1983 June 151 (11):2005-12. Epub 1900 01 01.

Phase II evaluation of phenesterin in patients with advanced ovarian cancer.

Bloom RE, Polivogianis L, Davis TE, Bennett JM, Horton J

Cancer treatment reports.. 1983 June 67 (6):601-2. Epub 1900 01 01.

Oncologists' views of cancer patient noncompliance.

Hoagland AC, Morrow GR, Bennett JM, Carnrike CL

American journal of clinical oncology.. 1983 April 6 (2):239-44. Epub 1900 01 01.

Oncologists' views of cancer patient noncompliance

Hoagland,A. C.; Morrow,G. R.; Bennett,J. M.; Carnrike,C. L.,Jr;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1983; 6(2): 239-244.

Treatment of Acute Leukemias

Bennett JM (Guest Editor), Boros L and Cohen H.

Your Patient and Cancer. 1983; : Articles I-V.

Informed consent to treatment in clinical trials.

Morrow GR, Bennett JM, Carpenter PJ

Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie.. 1983 37 (1):10-3. Epub 1900 01 01.

Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas.

O'Connell MJ, Anderson J, Merrill JM, Bennett JM, Glick JH, Berard CW, Neiman RS, Brodovsky HS

Cancer treatment reports.. 1982 December 66 (12):2021-5. Epub 1900 01 01.

Clinical and chemotherapeutic study of hepatocellular carcinoma in Malaysia: a comparison with African and American patients.

Joishy SK, Bennett JM, Balasegaram M, MacIntyre JM, Falkson G, Moertel C, Carbone PP

Cancer.. 1982 September 1550 (6):1065-9. Epub 1900 01 01.

Proposals for the classification of the myelodysplastic syndromes.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

British journal of haematology.. 1982 June 51 (2):189-99. Epub 1900 01 01.

Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.

Abramson N, Lurie P, Mietlowski WL, Schilling A, Bennett JM, Horton J

Cancer treatment reports.. 1982 June 66 (6):1273-7. Epub 1900 01 01.

High-dose radiation therapy with low-dose (pulsed) BCNU in malignant gliomas: an Eastern Cooperative Oncology Group (ECOG) report.

Salazar OM, VanHoutte PJ, Bennett JM, Rubin P, Wheeler KT

International journal of radiation oncology, biology, physics.. 1982 May 8 (5):915-9. Epub 1900 01 01.

Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.

Glick JH, Barnes JM, Bakemeier RF, Prosnitz LR, Bennett JM, Neiman RS, Costello W, Orlow EL

Cancer treatment reports.. 1982 April 66 (4):855-70. Epub 1900 01 01.

Cancer patient accessions into clinical trials: a pilot investigation into some patient and physician determinants of entry.

McCusker J, Wax A, Bennett JM

American journal of clinical oncology.. 1982 April 5 (2):227-36. Epub 1900 01 01.

Nodular histiocytic lymphoma: factors influencing prognosis and implications for aggressive chemotherapy.

Glick JH, McFadden E, Costello W, Ezdinli E, Berard CW, Bennett JM

Cancer.. 1982 March 149 (5):840-5. Epub 1900 01 01.

Anticipatory nausea and vomiting with chemotherapy.

Morrow GR, Arseneau JC, Asbury RF, Bennett JM, Boros L

The New England journal of medicine.. 1982 February 18306 (7):431-2. Epub 1900 01 01.

Burkitt cell leukemia following therapy for Hodgkin disease.

Nassar VH, Jacobs J, Mirra SS, Pandya KJ, Schwartz S, Bennett JM

American journal of hematology.. 1982 February 12 (1):73-6. Epub 1900 01 01.

Evaluation of bone marrow toxic reaction in patients treated with allopurinol.

Stolbach L, Begg C, Bennett JM, Silverstein M, Falkson G, Harris DT, Glick J

JAMA.. 1982 January 15247 (3):334-6. Epub 1900 01 01.

Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception.

Kim H, Zelman RJ, Fox MA, Bennett JM, Berard CW, Butler JJ, Byrne GE, Dorfman RF, Hartsock RJ, Lukes RJ, Mann RB, Neiman RS, Rebuck JW, Sheehan WW, Variakojis D, Wilson JF, Rappaport H

Journal of the National Cancer Institute.. 1982 January 68 (1):43-67. Epub 1900 01 01.

Cancer patient accessions into clinical trials: a pilot investigation into some patient and physician determinants of entry

McCusker,J.; Wax,A.; Bennett,J. M.;.

American Journal of Clinical Oncology : The Official Publication of the American Radium Society. 1982; 5(2): 227-236.

Cancer Patient Accessions into Clinical Trials: A Pilot Investigation into Some Patient and Physician Determinants of Entry.

McCusker J, Wax A, Bennett JM.

Cancer Clinical Trials. 1982; 5(2): 227-236.

The comparison of total body irradiation vs chlorambucil and prednisone for remission induction of active chronic lymphocytic leukemia: an ECOG study. Part I: total body irradiation-response and toxicity.

Rubin P, Bennett JM, Begg C, Bozdech MJ, Silber R

International journal of radiation oncology, biology, physics.. 1981 December 7 (12):1623-32. Epub 1900 01 01.

Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival.

Bennett JM, Begg CB

Cancer research.. 1981 November 41 (11 Pt 2):4833-7. Epub 1900 01 01.

Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy.

Glick JH, Barnes JM, Ezdinli EZ, Berard CW, Orlow EL, Bennett JM

Blood.. 1981 November 58 (5):920-5. Epub 1900 01 01.

Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases.

Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE, Bennett JM

Cancer.. 1981 September 1548 (6):1426-37. Epub 1900 01 01.

Treatment of metastatic breast cancer with aminoglutethimide.

Asbury RF, Bakemeier RF, Fölsch E, McCune CS, Savlov E, Bennett JM

Cancer.. 1981 April 1547 (8):1954-8. Epub 1900 01 01.

The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

British journal of haematology.. 1981 April 47 (4):553-61. Epub 1900 01 01.

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC

The American journal of medicine.. 1980 October 69 (4):491-7. Epub 1900 01 01.

Half-body and local chest irradiation as consolidation following response to standard induction chemotherapy for disseminated small cell lung cancer: an Eastern Cooperative Oncology Group pilot report.

Salazar OM, Creech RH, Rubin P, Bennett JM, Mason BA, Young JJ, Scarantino CW, Catalano RB

International journal of radiation oncology, biology, physics.. 1980 August 6 (8):1093-102. Epub 1900 01 01.

Marrow transplantation for acute nonlymphoblastic leukemia.

Begg CB, Bennett JM, Cassileth PA

The New England journal of medicine.. 1980 February 14302 (7):408-9. Epub 1900 01 01.

A variant form of hypergranular promyelocytic leukemia (M3).

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

Annals of internal medicine.. 1980 February 92 (2 Pt 1):261. Epub 1900 01 01.

Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults.

Skeel RT, Costello W, Bennett JM, Oken MM, Tobin MS, Bertino JR, Marsh JC, Carbone PP

Cancer.. 1980 January 1545 (2):224-31. Epub 1900 01 01.

Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology Group.

Ezdinli EZ, Costello WG, Icli F, Lenhard RE, Johnson GJ, Silverstein M, Berard CW, Bennett JM, Carbone PP

Cancer.. 1980 January 1545 (2):261-7. Epub 1900 01 01.

A variant form of hypergranular promyelocytic leukaemia (M3).

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

British journal of haematology.. 1980 January 44 (1):169-70. Epub 1900 01 01.

Acquired Acute Hemolytic Anemia Secondary to Phenazopyridine.

Loughner JE, Bennett JM.

Drug Intell Clin Pharm, Case Report. 1980; : 14861-863.

Pilot studies and new agent programs of the Eastern Cooperative Oncology Group.

Bennett JM, Zelen M

Cancer treatment reports.. 1980 64 (2-3):525-32. Epub 1900 01 01.

Non-Hodgkin's lymphoma and acute myeloblastic leukemia: a report of 12 cases and review of the literature.

Zarrabi MH, Rosner F, Bennett JM

Cancer.. 1979 September 44 (3):1070-80. Epub 1900 01 01.

Bleomycin.

Bennett JM, Reich SD

Annals of internal medicine.. 1979 June 90 (6):945-8. Epub 1900 01 01.

Changes in physicians' attitudes toward telling the cancer patient.

Novack DH, Plumer R, Smith RL, Ochitill H, Morrow GR, Bennett JM

JAMA.. 1979 March 2241 (9):897-900. Epub 1900 01 01.

Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.

Hahn RG, Bauer M, Wolter J, Creech R, Bennett JM, Wampler G

Cancer treatment reports.. 1979 March 63 (3):513-5. Epub 1900 01 01.

Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomas.

Ezdinli EZ, Costello W, Wasser LP, Lenhard RE, Berard CW, Hartsock R, Bennett JM, Carbone PP

Cancer.. 1979 February 43 (2):544-50. Epub 1900 01 01.

VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).

Chiuten DF, Bennett JM, Creech RH, Glick J, Falkson G, Brodovsky HS, Begg CB, Muggia FM, Carbone PP

Cancer treatment reports.. 1979 January 63 (1):7-11. Epub 1900 01 01.

Acute myelogenous leukemia.

Bennett JM

Medical and pediatric oncology.. 1979 7 (3):299. Epub 1900 01 01.

Diffuse well-differentiated lymphocytic lymphoma (DLWD): response and survival.

Icli F, Ezdinli EZ, Costello W, Berard CW, Bennett JM, Carbone PP

Cancer.. 1978 October 42 (4):1936-42. Epub 1900 01 01.

Phase II study of adriamycin and bleomycin in patients with multiple myeloma.

Bennett JM, Silber R, Ezdinli E, Levitt M, Oken M, Bakemeier RF, Bailar JC, Carbone PP

Cancer treatment reports.. 1978 September 62 (9):1367-9. Epub 1900 01 01.

Treatment of histiocytic and mixed lymphomas: a comparison of two, three and four drug chemotherapy.

Lenhard RE, Ezdinli EZ, Costello W, Bennett JM, Horton J, Amorisi EL, Stolbach L, Wolter J

Cancer.. 1978 July 42 (1):41-52. Epub 1900 01 01.

Postsplenectomy thrombocytosis: its association with mesenteric, portal, and/or renal vein thrombosis in patients with myeloproliferative disorders.

Gordon DH, Schaffner D, Bennett JM, Schwartz SI

Archives of surgery.. 1978 June 113 (6):713-5. Epub 1900 01 01.

Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma.

Ezdinli EZ, Costello W, Lenhard RE, Bakemeier R, Bennett JM, Berard CW, Carbone PP

Cancer.. 1978 May 41 (5):1900-6. Epub 1900 01 01.

The analytic basis for the use of platelet estimates from peripheral blood smears. Laboratory and clinical applications.

Nosanchuk JS, Chang J, Bennett JM

American journal of clinical pathology.. 1978 April 69 (4):383-7. Epub 1900 01 01.

Acute leukemia and non-hodgkin lymphoma.

Zarrabi MH, Rosner F, Bennett JM

The New England journal of medicine.. 1978 February 2298 (5):280. Epub 1900 01 01.

A Phase II Study of Estradiol Mustard

Schapira D, Hall TC, Bennett JM, Lavin P, Colsky J, Perlia C, Brodovsky H, Shnider B.

ECOG Cancer Clinical Trials. 1978; 1(1): 5-8.

Management of malignant pleural effusion.

Greenwald DW, Phillips C, Bennett JM

Journal of surgical oncology.. 1978 10 (4):361-8. Epub 1900 01 01.

A phase II study of phenesterin (NSC-104469).

Bennett JM, Frank J, Sears M, Lagakos SW, Horton J, Colsky J, Hall TC

Medical and pediatric oncology.. 1978 4 (3):241-6. Epub 1900 01 01.

Classification of acute leukemia.

Annals of internal medicine.. 1977 December 87 (6):740-53. Epub 1900 01 01.

Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.

Bennett JM, Lenhard RE, Ezdinli E, Johnson GJ, Carbone PP, Pocock SJ

Cancer treatment reports.. 1977 September 61 (6):1079-83. Epub 1900 01 01.

Myocardial imaging with Cc-99m pyrophosphate in patients on adriamycin treatment for neoplasia.

Chacko AK, Gordon DH, Bennett JM, O'Mara RE, Wilson GA

Journal of nuclear medicine : official publication, Society of Nuclear Medicine.. 1977 July 18 (7):680-3. Epub 1900 01 01.

Adjuvant oncotherapy: the treatment of systemic micrometastases.

Bennett JM

Advances in surgery.. 1977 11 :375-84. Epub 1900 01 01.

Adult acute leukemia. The Rochester (NY) Experience.

Enck RE, Bauman AW, Bennett JM

Archives of internal medicine.. 1976 November 136 (11):1256-61. Epub 1900 01 01.

Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress report.

Ezdinli E, Pocock S, Berard CW, Aungst CW, Silverstein M, Horton J, Bennett J, Bakemeier R, Stolbach L, Perlia C, Brunk SF, Lenhard RE, Klaassen DJ, Richter P, Carbone P

Cancer.. 1976 September 38 (3):1060-8. Epub 1900 01 01.

Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C

British journal of haematology.. 1976 August 33 (4):451-8. Epub 1900 01 01.

Isolation of Haemophilus aphrophilus from an adult with acute leukemia.

Enck RE, Bennett JM

Journal of clinical microbiology.. 1976 August 4 (2):194-5. Epub 1900 01 01.

Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.

Edmonson JH, Lagakos SW, Selawry OS, Perlia CP, Bennett JM, Muggia FM, Wampler G, Brodovsky HS, Horton J, Colsky J, Mansour EG, Creech R, Stolbach L, Greenspan EM, Levitt M, Israel L, Ezdinli EZ, Carbone PP

Cancer treatment reports.. 1976 July 60 (7):925-32. Epub 1900 01 01.

Immune markers in adult acute leukemia.

Abramson N, DeLuca J, Bennett JM

American journal of clinical pathology.. 1976 July 66 (1):111-6. Epub 1900 01 01.

Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.

Bennett JM, Bakemeier RF, Carbone PP, Ezdinli E, Lenhard RE

Cancer treatment reports.. 1976 June 60 (6):739-45. Epub 1900 01 01.

Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung.

Edmonson JH, Lagakos S, Stolbach L, Perlia CP, Bennett JM, Mansour EG, Horton J, Regelson W, Cummings FJ, Israel L, Brodsky I, Shnider BI, Creech R, Carbone PP

Cancer treatment reports.. 1976 May 60 (5):625-7. Epub 1900 01 01.

Carcinocythemia (carcinoma cell leukemia). An acute leukemia-like picture due to metastatic carcinoma cells.

Carey RW, Taft PD, Bennett JM, Kaufman S

The American journal of medicine.. 1976 February 60 (2):273-8. Epub 1900 01 01.

The acquisition of granylocytes by leukapheresis: a comparison of continuous flow centrifugation and filtration leukapheresis in normal and corticosteroid-stimulated donors.

MacPherson JL, Nusbacher J, Bennett JM

Transfusion.. 1976 16 (3):221-8. Epub 1900 01 01.

Chronic lymphocytic leukemia: therapeutic options.

Bennett JM

International journal of radiation oncology, biology, physics.. 1976 1 (5-6):559-60. Epub 1900 01 01.

N-acetyl-beta-glucosaminidase activity in normal and malignant leukocytes.

Reed CE, Bennett JM

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.. 1975 October 23 (10):752-7. Epub 1900 01 01.

Inappropiate ADH secretion associated with massive vincristine overdosage.

Wakem CJ, Bennett JM

Australian and New Zealand journal of medicine.. 1975 June 5 (3):266-9. Epub 1900 01 01.

Acute Leukemia Cytochemical Profile: Diagnostic and Clinical Implications.

Bennett JM, Reed CE.

Blood Cells. 1975; 1: 101-113.

Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.

Horton J, Mittelman A, Taylor SG, Jurkowitz L, Bennett JM, Ezdinli E, Colsky J, Hanley JA

Cancer chemotherapy reports. Part 1.. 1975 59 (2 Pt 1):333-40. Epub 1900 01 01.

Nitroblue tetrazolium test in Hodgkin disease and other malignant lymphomas.

Chang JC, Appleby J, Bennett JM

Archives of internal medicine.. 1974 March 133 (3):401-3. Epub 1900 01 01.

Diagnosis of Leukemia

Wakem CJ, Bennett JM.

Current Diagnosis. 4th Edition. 1974; .

Nonspherocytic haemolytic anaemia with increased red cell adenine nucleotides, glutathione and basophilic stippling and ribosephosphate pyrophosphokinase (RPK) deficiency: studies on two new kindreds.

Valentine WN, Bennett JM, Krivit W, Konrad PN, Lowman JT, Paglia DE, Wakem CJ

British journal of haematology.. 1973 February 24 (2):157-67. Epub 1900 01 01.

The Classification of Malignant Lymphomas

Bennett JM, Werner RJ.

MedCom, Inc., Self-Teaching Aid. 1973; .

Malignant Disease of the Hematopoietic System

K Akazaki, H Rappaport, C Berard, J Bennett, E Ishikawa.

Japanese Cancer Association. 1973; .

Survival prediction based on morphology of lymphoblasts.

Bennett JM, Klemperer MR, Segel GB

Recent results in cancer research. Fortschritte der Krebsforschung.

Hodgkin's disease terminating as acute leukaemia: case report and review of the literature.

Wakem CJ, Bennett JM

The New Zealand medical journal.. 1972 September 76 (484):187-94. Epub 1900 01 01.

Modification of strychnine-induced convulsions by anticonvulsants in the frog.

Bennett JM

Neuropharmacology.. 1972 March 11 (2):297-9. Epub 1900 01 01.

Hodgkin's Disease Terminating as Acute Leukemia: A Case Report and Review of the Literature.

Bennett JM, Wakem CJ.

N Zeal Med J. 1972; 76: 187-194.

Am improved cytochemical method for nitroblue tetra-zolium reduction by neutrophils.

Hicks RG, Bennett JM

The American journal of medical technology.. 1971 June 37 (6):226-9. Epub 1900 01 01.

Myelomonocytic leukemias: a historical review and perspectives.

Bennett JM

Cancer.. 1971 May 27 (5):1218-20. Epub 1900 01 01.

Bone marrow lymphocytosis in acute leukemia: a second look.

Skeel RT, Bennett JM, Henderson ES

Blood.. 1970 March 35 (3):356-60. Epub 1900 01 01.

Relation of dopa and 5-HTP to convulsions induced by strychnine and leptazol.

Bennett JM

European journal of pharmacology.. 1970 January 9 (1):27-30. Epub 1900 01 01.

Giant neutrophil granules in the Chediak-Higashi syndrome of man, mink, cattle and mice.

Blume RS, Padgett GA, Wolff SM, Bennett JM

Canadian journal of comparative medicine. Revue canadienne de

Pyridoxine-responsive anemia.

Rosenberg SJ, Bennett JM

New York state journal of medicine.. 1969 June 169 (11):1430-3. Epub 1900 01 01.

Burkitt's tumor in the United States.

Cohen MH, Bennett JM, Berard CW, Ziegler JL, Vogel CL, Sheagren JN, Carbone PP

Cancer.. 1969 June 23 (6):1259-72. Epub 1900 01 01.

Lymphoblastic leukaemia.

Bennett JM, Henderson ES

British medical journal.. 1969 May 242 (5655):513. Epub 1900 01 01.

Cyclophosphamide vs melphalan in myeloma.

Bennett JM

JAMA.. 1969 April 21208 (3):536. Epub 1900 01 01.

NIH clinical staff conference. Burkitt's tumor.

Carbone PP, Berard CW, Bennett JM, Ziegler JL, Cohen MH, Gerber P

Annals of internal medicine.. 1969 April 70 (4):817-32. Epub 1900 01 01.

Cytogenetic findings in erythroleukemia.

Heath CW, Bennett JM, Whang-Peng J, Berry EW, Wiernick PH

Blood.. 1969 March 33 (3):453-67. Epub 1900 01 01.

Evaluation studies of peripheral blood leukocyte changes in malignancy.

Malmgren RA, Bennett JM, Del Vecchio PR, DeWitt SH, Feld M, Kazam E, Schneiderman MA

Acta cytologica.. 1969 March 13 (3):149-53. Epub 1900 01 01.

A successful safari.

Bennett JM

The New England journal of medicine.. 1969 February 6280 (6):328-9. Epub 1900 01 01.

The cytochemistry of acute leukemia: observations on glycogen and neutral fat in bone marrow aspirates.

Bennett JM, Dutcher TF

Blood.. 1969 February 33 (2):341-7. Epub 1900 01 01.

Combination chemotherapy in accelerated phase of chronic granulocytic leukemia.

Foley HT, Bennett JM, Carbone PP

Archives of internal medicine.. 1969 February 123 (2):166-70. Epub 1900 01 01.

Characterization and significance of abnormal leukocyte granules in the beige mouse: a possible homologue for Chediak-Higashi Aleutian trait.

Bennett JM, Blume RS, Wolff SM

The Journal of laboratory and clinical medicine.. 1969 February 73 (2):235-43. Epub 1900 01 01.

Chemotherapy for Plasma Cell Myeloma

Bennett JM.

J Am Med Assoc. 1969; 208: 536.

Definition of Burkitt's Tumor- Meeting of Investigators on the Histopathology of Burkitt's Tumor

Bennett JM.

Bull of Who (World Health Organization). 1969; 40: 601-607.

The effects of infusing thrombin and its acetylated derivative. II. Observations on intravascular hemolysis with pathologic correlations.

Bennett JM, Yu D, Suyemoto J, Pechet L

Thrombosis et diathesis haemorrhagica. 1968 December 3120 (3):469-76. Epub 1900 01 01.

The staging of Hodgkin's disease.

de Vita VT, Bennett JM, Foley HT, Cohen MH, Gralnick HR

Revue française d'études cliniques et biologiques. 1968 December 13 (10):1004-6. Epub 1900 01 01.

Defective granulocyte regulation in the Chediak-Higashi syndrome.

Blume RS, Bennett JM, Yankee RA, Wolff SM

The New England journal of medicine.. 1968 November 7279 (19):1009-15. Epub 1900 01 01.

The significance of bone marrow lymphocytosis of acute leukemia patients in remission.

Skeel RT, Henderson ES, Bennett JM

Blood.. 1968 November 32 (5):767-73. Epub 1900 01 01.

Solitary myeloma of the lumbar spine successfully treated with radiation. Report of a case.

Kaplan GA, Bennett J

Radiology.. 1968 November 91 (5):1017-8 passim. Epub 1900 01 01.

A new semiautomated method for the concentration of cerebrospinal fluid for cytologic examination.

Bennett JM, Ruberg J, Dixon S

American journal of clinical pathology.. 1968 October 50 (4):533-6. Epub 1900 01 01.

A new semiautomated method for the concentration of cerebrospinal fluid for cytologic examination.

Bennett JM, Ruberg J, Dixon S

Technical bulletin of the Registry of Medical Technologists.. 1968 September 38 (9):247-50. Epub 1900 01 01.

Cytogenic studies in metastatic neuroblastoma.

Whang-Peng J, Bennett JM

American journal of diseases of children. 1968 June 115 (6):703-8. Epub 1900 01 01.

Bone-marrow biopsy in Hodgkin's disease.

Bennett JM, Gralnick HR, Devita VT

The New England journal of medicine.. 1968 May 23278 (21):1179. Epub 1900 01 01.

Significance of leukocyte alkaline phosphatase in Hodgkin's disease.

Bennett JM, Nathanson L, Rutenburg AM

Archives of internal medicine.. 1968 April 121 (4):338-41. Epub 1900 01 01.

Cytogenetic Findings in Neuroblastoma

Whang J, Bennett JM.

American J Dis Children. 1968; 115: 703.

A New Semi-Automated Method for the Concentration of Cerebrospinal Fluid for Cytologic Examination.

Bennett JM, Rubert J, Dixon S.

Am J Clin Path and Tech Bul. 1968; 49: 533-536.

The Effects of Infusing Thrombin and its Acetylated Derivative:II. Observations on Intravascular Hemolysis with Pathologic Correlations

Bennett JM, Ju D, Suyemoto, Pechet L.

Throm et Diath Hemorr. 1968; 20(1163): 294-301.

Quinine-induced haemolysis: mechanism of action.

Bennett JM, Desforges JF

British journal of haematology.. 1967 September 13 (5):706-12. Epub 1900 01 01.

Histochemical demonstration of leucocyte acid phosphatase in health and in disease.

Rosales CL, Bennett JM, Rutenbug AM

British journal of haematology.. 1966 March 12 (2):172-6. Epub 1900 01 01.

Diagnostic value of leukocyte alkaline phosphatase: a three year experience.

Bennett JM, Rutenburg AM

Annales d'histochimie. 1966 11 (2):173-81. Epub 1900 01 01.

Erythrocyte metabolism in hemolysis.

Desforges JF

The New England journal of medicine.. 1965 December 9273 (24):1310-21. Epub 1900 01 01.

AN IMPROVED HISTOCHEMICAL METHOD FOR THE DEMONSTRATION OF LEUKOCYTE ALKALINE PHOSPHATASE ACTIVITY: CLINICAL APPLICATION.

RUTENBURG M, ROSALES CL, BENNETT JM

The Journal of laboratory and clinical medicine.. 1965 April 65 :698-705. Epub 1900 01 01.

Mechanism of Action of C. Welchii Hemolytic Anemia

Bennett JM, Desforges JF.

Lancet. 1964; 7343: 834.

Spherocytic Hemolytic Anemia and Acute Cholecystitis Caused by Clostridium Welchii.

Bennett JM, Healy PJM.

New England Journal of Medicine. 1963; 268: 1070.

A new instrument for common duct exploration.

BENNETT JM

New York state journal of medicine.. 1958 May 1558 (10):1686-7. Epub 1900 01 01.

Observations on Myelofibrosis and the Accelerated Phase. Symposium on Myeloproliferative Disorders of Animals and Man, Division of Technical Information, US Atomic Energy Commission presented at Richland, Washington, May 20, 1968.

Gralnick HR, Bennett JM.

Bone Marrow Histology in Chronic Granulocytic Leukemia. .

The classification and management of the myelodysplastic syndromes: Areas of controversy.

Bennett JM.

Hematology Reviews. 7: 189-197.

Books

Cecil Textbook of Medicine (2004)

Chapter: The peripheral blood smear: clues to clinically important diseases.

Authors: Bennett JM and Shafer JA.

Publisher: W. B. Saunders Company 2004

Molecular Biology, Pathology, and Cytogenetics (2004)

Authors: Komrokji R, Bennett JM.

Publisher: McGraw-Hill Book 2004

Neoplastic Diseases of the Blood (2003)

Chapter: Classification of acute leukemias: cytochemical and morphologic considerations

Authors: Tuzuner NN., Bennett JM. In Wiernik P, Goldman J, Dutcher J, and Kyle R.

Publisher: Cambridge University Press 2003

Pathobiology and Clinical Management. (2002)

Chapter: The Myelodysplastic Syndromes

Authors: Bennett JM, (ed)

Publisher: Marcel Dekker, Inc., New York 2002

The Myelodysplastic Syndromes: Pathobiology and Clinical Management. (2002)

Chapter: Myelodysplastic syndromes: Historical aspects and classification.

Authors: Phelan JT II, Kouides PA, and Bennett J.M.

Publisher: Marcel Dekker, Inc., New York 2002

World Health Organization Classification of Tumours: Pathology and Genetics of T (2001)

Chapter: Chronic myelomonocytic leukaemia"

Authors: Vardiman, JW, Pierre R, Bain B, Bennett JM, Imbert M, Brunning RD. Flandrin G.

Publisher: IARC Press 2001

World Health Organization Classification of Tumours: Pathology and Genetics of T (2001)

Chapter: Myelodysplastic syndromes.

Authors: Brunning RD, Bennett JM, Flandrin G, Matutes E, Head D, Vardiman JW, Harris, NL.

Publisher: IARC Press 2001

World Health Organization Classification of Tumours: Pathology and Genetics of T (2001)

Chapter: Acute myeloid leukaemia.

Authors: Brunning RD, Matutes E, Harris NL, Flandrin G, Vardiman J, Bennett JM, Head D.

Publisher: IARC Press 2001

World Health Organization Classification of Tumours: Pathology and Genetics of T (2001)

Chapter: Precursor B-and T-cell neoplasms.

Authors: Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow SH, Bennett JM.

Publisher: IARC Press 2001

Leukemia Research (2001)

Chapter: Cancer vaccines and immunotherapy.

Authors: Bennett JM.

Publisher: Cambridge Univ. Press. 2001

Leukemia Research (2000)

Chapter: Modern Hematology: Biology and Clinical Management.

Authors: Bennett JM.

Publisher: Humana Press. 2000

Book Review Leukemia Research (2000)

Chapter: Aplastic Anemia: Pathophysiology and treatment.

Authors: Bennett JM.

Publisher: Cambridge Univ Press 2000

Acute Leukemias VI: Prognostic Factors and Treatment Strategies (1997)

Chapter: Cytomorphology and clinical outcome in 80 patients with AML M4Eo and inversion l6.

Authors: Haferlach T, Loffler H, Bennett JM, Andersen JW, Gassmann W, Schoch R, Paietta E, Cassileth PA, Fonatsch C, Schoch C, Schlegelberger B, Becher R, Thiel E, Ludwig W-D, Sauerland MC, Heinecke A, Buchner T.

Publisher: - 1997

Neoplastic Diseases of the Blood. (1995)

Chapter: Classification of the acute leukemias: Cytochemical and morphologic considerations

Authors: Tuzuner NN, Bennett JM.

Publisher: - 1995

Acute Leukemias IV: Prognostic Factors (1994)

Chapter: Clinical trials in adults with acute myelogenous leukemia: Experience of the Eastern Cooperative Oncology Group.

Authors: Rowe JM, Andersen JW, Cassileth PA, Oken MM, Bennett JM, Wiernik PH

Publisher: Springer-Verlag 1994

Acute Leukemias IV: Prognostic Factors. (1994)

Chapter: Treatment of relapsed and refractory AML with Mitoxantrone and Etoposide: A study of the Eastern Cooperative Oncology Group.

Authors: Rowe JM, Andersen JW, Mazza JJ, Hines JD, Bennett JM, Cassileth PA. Mansour E and Oken MM.

Publisher: - 1994

Clinical Oncology (1993)

Chapter: Basic concepts in investigational therapeutics and clinical trials.

Authors: Bennett JM.

Publisher: WB Saunders Pub 1993

Myelodysplastic Syndromes (1992)

Chapter: The Classification of Myelodysplastic Syndromes.

Authors: Bennett, JM.

Publisher: Springer-Verlag 1992

Myelodysplastic Syndromes. (1992)

Chapter: Phase III evaluation of low-dose Cytosine Arabinoside versus supportive care in the treatment of adults with myelodysplastic syndrome.

Authors: Bennett JM, Miller KB, Kim K, Morrison FS, Winter JN, Cassileth P, Neiman RS, Head D.

Publisher: Springer-Verlag 1992

Medical Care of the Cancer Patient (1992)

Chapter: The Chronic Leukemias.

Authors: Bennett JM.

Publisher: WB Saunders Co 1992

Acute Lymphoblastic Leukemia (1990)

Chapter: High-Dose Cytarabine Therapy in Adult Acute Lymphocytic Leukemia.

Authors: Cassileth PA, Andersen JW, Hoagland HC, Mazza JJ, Bennett JM, Hahn, RG, Tormey DC, O'Connell MJ

Publisher: Liss Inc. 1990

The Biology of Human Leukemia (1990)

Chapter: The diagnosis of the acute and chronic leukemias: Morphologic considerations.

Authors: Bennett JM

Publisher: John Hopkins Univ Press 1990

Acute myelogenous Leukemia: Progress and Controversies (1990)

Chapter: Clinical trials in adults with acute myelogenous leukemia: The ECOG experience.

Authors: Rowe JM, Cassileth PA, Oken MM, Andersen JW, Bennett JM, and Wiernik PH

Publisher: Wiley-Liss Pub 1990

Acute Myelogenous Leukemia: Progress and Controversies (1990)

Chapter: Clinical trials in adults with acute myelogenous leukemia: The ECOG experience.

Authors: Rowe JM, Cassileth PA, Oken MM, Andersen JW, Bennett JM and Wiernik PH.

Publisher: Wiley-Liss Inc 1990

Criteria for Diagnosis (1989)

Chapter: Myelodysplastic Syndromes.

Authors: Bennett JM

Publisher: - 1989

Medicine for the Practicing Physician (1988)

Chapter: Myelodysplastic Syndromes.

Authors: Bennett JM

Publisher: - 1988

Immunologic Approaches to the Classification and Management of Lymphomas and Leu (1988)

Authors: Bennett JM, Foon K (Eds)

Publisher: Kluwer Publisher 1988

Chronic Lymphocytic Leukemia: Recent Progress and Future Direction (1987)

Chapter: Comparison of chlorambucil & Prednisone vs Total Body Irradiation & Chlorambucil:Prednisone vs Cytoxan, Vincristine, Prednisone for the Therapy of Active Chronic Lymphocytic Leukemia

Authors: Bennett JM Raphael B, Moore D, Silber R, Oken MM and Rubin P

Publisher: A.R. Liss, Inc 1987

Medical Care of the Cancer Patient. (1987)

Chapter: The Acute and Chronic Leukemias

Authors: Bennett JM ,

Publisher: WB Saunders Co. 1987

Neoplastic Diseases of the Blood (1984)

Chapter: The Classification of the acute Leukemias:Cytochemical and Morphologic Considerations.

Authors: Bennett JM

Publisher: - 1984

Hematol. 1: Leukemias (1984)

Chapter: The Acute Myeloid Leukemias.

Authors: Boros L, Bennett JM

Publisher: - 1984

Hematology 1: Leukemias (1984)

Chapter: The acute myeloid leukemias.

Authors: Bennett JM, and Boros L

Publisher: - 1984

Clinical Oncology for Medical Students (1983)

Chapter: Basic Concepts in Investigational Therapeutics.

Authors: Bennett JM

Publisher: Amer Cancer Society 1983

Leukemia (1982)

Chapter: Leukemia Morphology and Cytochemistry

Authors: Bennett JM

Publisher: - 1982

Adult Leukemias I (1982)

Chapter: The French-American-British classification of the acute adult myeloid leukemias: Its clinical relevance.

Authors: Bennett JM

Publisher: - 1982

Cancer and Chemotherapy (1981)

Chapter: The Lymphomas

Authors: Bennett JM

Publisher: Academic Press 1981

Practical Cancer Chemotherapy (1981)

Chapter: The Acute and Chronic Leukemias.

Authors: Bennett JM

Publisher: Medical Examination Publishing Co., Inc 1981

Practical Cancer Chemotherapy (1981)

Chapter: Malignant Brain Tumors.

Authors: Bennett JM

Publisher: Medical Examination Publishing Co., Inc. 1981

Principles of Cancer Treatment. (1981)

Chapter: Chronic Granulocytic Leukemia.

Authors: Bennett JM

Publisher: McGraw Hill, New York 1981

Science and Practice of Clinical Medicine 6 (1980)

Chapter: Chronic Lymphocytic Leukemia. Chapt on Hematology and Oncology.

Authors: Bennett JM, Lichtman MA

Publisher: - 1980

Science and Practice of Clinical Medicine 6 (1980)

Chapter: Hairy Cell Leukemia. Chapt on Hematology and Oncology.

Authors: Bennett JM

Publisher: - 1980

Part I: Hodgkin's Disease. 2nd ed (1980)

Chapter: Classification of Malignant Lymphomas

Authors: Neiman RS, Bennett JM

Publisher: MEDCOM, Inc. 1980

Cancer Research: Impact of the Cooperative Groups (1980)

Chapter: Wiernik PH Adult Acute Leukemia.

Authors: Freireich EJ, Bennett JM, Vogler RW

Publisher: - 1980

Cancer Chemotherapy (1979)

Chapter: The Chemotherapy of Non-Hodgkin's Lymphoma.

Authors: Bennett JM

Publisher: Grune and Stratton, Inc, NYC 1979

Leukemia Cells (1979)

Chapter: The Cytochemistry of the Leukemia Cell.

Authors: Reed CE, Bennett JM

Publisher: CRC Press, Inc., W. Palm Beach 1979

Hematology for Practitioners (1978)

Chapter: Lymphadenopathy Without Lymphocytosis.

Authors: Bennett JM, Lichtman MA

Publisher: Little, Brown & Co. 1978

Clinical Oncology (1978)

Chapter: A Manual for Students and Doctors. 2nd Edition.

Authors: Bennett JM

Publisher: Springer-Verlag, NY 1978

Ther Acute Leuk (1977)

Chapter: The Cytochemistry of Acute Nonlymphocytic Leukemia: Correlations with Responses in Two Eastern Cooperative Oncology Group Trials. Proc 2nd Intern Symp

Authors: Bennett JM, Begg CB, Sartiano G, Skeel R, Carbone PP

Publisher: Rome 1977

Hematology for Internists (1971)

Chapter: The Classification and Staging of Lymphoma

Authors: Bennett JM

Publisher: Little, Brown & Co. 1971

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.